Till sidinnehåll
Kunskapsbank för cancervården Till cancercentrum.se

Referenser

Abu-Rustum, N. R., Sonoda, Y., Black, D., Levine, D. A., Chi, D. S., & Barakat, R. R. (2006). Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature. Gynecol Oncol, 103(3), 807-813. doi:10.1016/j.ygyno.2006.05.044

Achouri, A., Huchon, C., Bats, A. S., Bensaid, C., Nos, C., & Lecuru, F. (2013). Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol, 39(1), 81-86. doi:10.1016/j.ejso.2012.10.011

Ahlin, R., Sjoberg, F., Bull, C., Steineck, G., & Hedelin, M. (2018). [Differing dietary advice are given to gynaecological and prostate cancer patients receiving radiotherapy in Sweden]. Lakartidningen, 115.

Ahmad, R., Bondar, L., Voet, P., Mens, J. W., Quint, S., Dhawtal, G.,  Hoogeman, M. (2013). A margin-of-the-day online adaptive intensity-modulated radiotherapy strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins: a dosimetric evaluation. Acta Oncol, 52(7), 1430-1436. doi:10.3109/0284186X.2013.813640

Ahmad, R., Hoogeman, M. S., Quint, S., Mens, J. W., de Pree, I., & Heijmen, B. J. (2008). Inter-fraction bladder filling variations and time trends for cervical cancer patients assessed with a portable 3-dimensional ultrasound bladder scanner. Radiother Oncol, 89(2), 172-179. doi:10.1016/j.radonc.2008.07.005

Al-Kurdi, M., & Monaghan, J. M. (1981). Thirty-two years experience in management of primary tumours of the vagina. Br J Obstet Gynaecol, 88(11), 1145-1150.

Alemany, L., Saunier, M., Tinoco, L., Quiros, B., Alvarado-Cabrero, I., Alejo, M.,  group, H. V. s. (2014). Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer, 50(16), 2846-2854. doi:10.1016/j.ejca.2014.07.018

Alfonzo, E., Wallin, E., Ekdahl, L., Staf, C., Radestad, A. F., Reynisson, P.,  Dahm-Kahler, P. (2019). No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study. Eur J Cancer, 116, 169-177. doi:10.1016/j.ejca.2019.05.016

Alfsen, G. C., Kristensen, G. B., Skovlund, E., Pettersen, E. O., & Abeler, V. M. (2001). Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix. Cancer, 92(9), 2471-2483.

Allgood, J. W., Langberg, C. W., Sung, C. C., & Hauer-Jensen, M. (1996). Timing of concomitant boost irradiation affects incidence and severity of intestinal complications. Int J Radiat Oncol Biol Phys, 34(2), 381-387.

Alonso, I., Felix, A., Torne, A., Fuste, V., del Pino, M., Castillo, P.,  Ordi, J. (2012). Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina. Gynecol Oncol, 125(1), 194-199. doi:10.1016/j.ygyno.2011.12.449

Alouini, S., Rida, K., & Mathevet, P. (2008). Cervical cancer complicating pregnancy: implications of laparoscopic lymphadenectomy. Gynecol Oncol, 108(3), 472-477. doi:10.1016/j.ygyno.2007.12.006

Alsadius, D., Hedelin, M., Johansson, K. A., Pettersson, N., Wilderang, U., Lundstedt, D., & Steineck, G. (2011). Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer. Radiother Oncol, 101(3), 495-501. doi:10.1016/j.radonc.2011.06.010

Amant, F., Halaska, M. J., Fumagalli, M., Dahl Steffensen, K., Lok, C., Van Calsteren, K., Pregnancy, E. t. f. C. i. (2014). Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer, 24(3), 394-403. doi:10.1097/IGC.0000000000000062

Amant, F., Van Calsteren, K., Halaska, M. J., Gziri, M. M., Hui, W., Lagae, L., Ottevanger, P. B. (2012). Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol, 13(3), 256-264. doi:10.1016/S1470-2045(11)70363-1

Amant, F., Vandenbroucke, T., Verheecke, M., Fumagalli, M., Halaska, M. J., Boere, I., Van Calsteren, K. (2015). Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med, 373(19), 1824-1834. doi:10.1056/NEJMoa1508913

Andrae, B., Andersson, T. M., Lambert, P. C., Kemetli, L., Silfverdal, L., Strander, B., Sparen, P. (2012). Screening and cervical cancer cure: population based cohort study. BMJ, 344, e900. doi:10.1136/bmj.e900

Andrae, B., Kemetli, L., Sparen, P., Silfverdal, L., Strander, B., Ryd, W., Tornberg, S. (2008). Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst, 100(9), 622-629. doi:10.1093/jnci/djn099

Ang, C., Bryant, A., Barton, D. P., Pomel, C., & Naik, R. (2014). Exenterative surgery for recurrent gynaecological malignancies. Cochrane Database Syst Rev, 2, CD010449. doi:10.1002/14651858.CD010449.pub2

Annon, J. S. (1976). The PLISSIT Model: A Proposed Conceptual Scheme for the Behavioral Treatment of Sexual Problems. Journal of Sex Education and Therapy, 2(1), 1-15. doi:10.1080/01614576.1976.11074483

Aoki, Y., Sasaki, M., Watanabe, M., Sato, T., Tsuneki, I., Aida, H., & Tanaka, K. (2000). High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol, 77(2), 305-309. doi:10.1006/gyno.2000.5788

Armuand, G. M., Rodriguez-Wallberg, K. A., Wettergren, L., Ahlgren, J., Enblad, G., Hoglund, M., & Lampic, C. (2012). Sex differences in fertility-related information received by young adult cancer survivors. J Clin Oncol, 30(17), 2147-2153. doi:10.1200/JCO.2011.40.6470

Au, S. P., & Grigsby, P. W. (2003). The irradiation tolerance dose of the proximal vagina. Radiother Oncol, 67(1), 77-85.

Baiocchi, G., Guimaraes, G. C., Faloppa, C. C., Kumagai, L. Y., Oliveira, R. A., Begnami, M. D., Lopes, A. (2013). Does histologic type correlate to outcome after pelvic exenteration for cervical and vaginal cancer? Ann Surg Oncol, 20(5), 1694-1700. doi:10.1245/s10434-012-2768-6

Bakker, R. M., Mens, J. W., de Groot, H. E., Tuijnman-Raasveld, C. C., Braat, C., Hompus, W. C., Ter Kuile, M. M. (2017). A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer. Support Care Cancer, 25(3), 729-737. doi:10.1007/s00520-016-3453-2

Balleyguier, C., Sala, E., Da Cunha, T., Bergman, A., Brkljacic, B., Danza, F., Kinkel, K. (2011). Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol, 21(5), 1102-1110. doi:10.1007/s00330-010-1998-x

Barillot, I., Horiot, J. C., Cuisenier, J., Pigneux, J., Schraub, S., Rozan, R., et al. (1993). Carcinoma of the cervical stump: a review of 213 cases. Eur J Cancer, 29A(9), 1231-1236.

Barnes, W., Waggoner, S., Delgado, G., Maher, K., Potkul, R., Barter, J., & Benjamin, S. (1991). Manometric characterization of rectal dysfunction following radical hysterectomy. Gynecol Oncol, 42(2), 116-119.

Barter, J. F., Soong, S. J., Shingleton, H. M., Hatch, K. D., & Orr, J. W., Jr. (1989). Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol, 32(3), 292-296.

Barwick, T. D., Taylor, A., & Rockall, A. (2013). Functional imaging to predict tumor response in locally advanced cervical cancer. Curr Oncol Rep, 15(6), 549-558. doi:10.1007/s11912-013-0344-2

Basu, P., Mehta, A., Jain, M., Gupta, S., Nagarkar, R. V., John, S., & Petit, R. (2018). A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer. Int J Gynecol Cancer, 28(4), 764-772. doi:10.1097/igc.0000000000001235

Bats, A. S., Mathevet, P., Buenerd, A., Orliaguet, I., Mery, E., Zerdoud, S., Lecuru, F. (2013). The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol, 20(2), 413-422. doi:10.1245/s10434-012-2597-7

Beesley, V., Janda, M., Eakin, E., Obermair, A., & Battistutta, D. (2007). Lymphedema after gynecological cancer treatment : prevalence, correlates, and supportive care needs. Cancer, 109(12), 2607-2614. doi:10.1002/cncr.22684

Beiner, M. E., Hauspy, J., Rosen, B., Murphy, J., Laframboise, S., Nofech-Mozes, S., Covens, A. (2008). Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer: a matched case-control study. Gynecol Oncol, 110(2), 168-171. doi:10.1016/j.ygyno.2008.04.027

Beller, U., Benedet, J. L., Creasman, W. T., Ngan, H. Y., Quinn, M. A., Maisonneuve, P., Heintz, A. P. (2006). Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 95 Suppl 1, S29-42. doi:10.1016/S0020-7292(06)60029-5

Benedet, J. L., & Anderson, G. H. (1996). Stage IA carcinoma of the cervix revisited. Obstet Gynecol, 87(6), 1052-1059.

Benedetti Panici, P., Basile, S., Maneschi, F., Alberto Lissoni, A., Signorelli, M., Scambia, G., Mangioni, C. (2008). Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst, 100(23), 1707-1716. doi:10.1093/jnci/djn397

Benedetti Panici, P., Bellati, F., Plotti, F., Di Donato, V., Antonilli, M., Perniola, G., Angioli, R. (2008). Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma. Gynecol Oncol, 111(2), 307-311. doi:10.1016/j.ygyno.2008.07.005

Benn, T., Brooks, R. A., Zhang, Q., Powell, M. A., Thaker, P. H., Mutch, D. G., & Zighelboim, I. (2011). Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol, 122(1), 14-18. doi:10.1016/j.ygyno.2011.03.003

Bentivegna, E., Maulard, A., Pautier, P., Chargari, C., Gouy, S., & Morice, P. (2016). Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature. Fertil Steril, 106(5), 1195-1211.e1195. doi:10.1016/j.fertnstert.2016.06.032

Benton, B., Norton, C., Lindsay, J. O., Dolan, S., & Andreyev, H. J. (2011). Can nurses manage gastrointestinal symptoms arising from pelvic radiation disease? Clin Oncol (R Coll Radiol), 23(8), 538-551. doi:10.1016/j.clon.2011.03.006

Bentzen, S. M., Constine, L. S., Deasy, J. O., Eisbruch, A., Jackson, A., Marks, L. B., Yorke, E. D. (2010). Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys, 76(3 Suppl), S3-9. doi:10.1016/j.ijrobp.2009.09.040

Bergmark, K., Avall-Lundqvist, E., Dickman, P. W., Henningsohn, L., & Steineck, G. (2002). Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand, 81(5), 443-450.

Bergmark, K., Avall-Lundqvist, E., Dickman, P. W., Henningsohn, L., & Steineck, G. (2006). Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer, 16(3), 1130-1139. doi:10.1111/j.1525-1438.2006.00601.x

Bergmark, K., Avall-Lundqvist, E., Dickman, P. W., Steineck, G., & Henningsohn, L. (2005). Synergy between sexual abuse and cervical cancer in causing sexual dysfunction. J Sex Marital Ther, 31(5), 361-383. doi:10.1080/00926230591006476

Beriwal, S., Gan, G. N., Heron, D. E., Selvaraj, R. N., Kim, H., Lalonde, R., Edwards, R. P. (2007). Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys, 68(1), 166-171. doi:10.1016/j.ijrobp.2006.12.023

Beriwal, S., Rwigema, J. C., Higgins, E., Kim, H., Houser, C., Sukumvanich, P., Krivak, T. C. (2012). Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer. Brachytherapy, 11(3), 176-180. doi:10.1016/j.brachy.2011.05.005

Bermudez, A., Vighi, S., Garcia, A., & Sardi, J. (2001). Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge. Gynecol Oncol, 82(1), 32-39. doi:10.1006/gyno.2001.6201

Bese, N. S., Hendry, J., & Jeremic, B. (2007). Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys, 68(3), 654-661. doi:10.1016/j.ijrobp.2007.03.010

Bhatla, N., Berek, J. S., Cuello Fredes, M., Denny, L. A., Grenman, S., Karunaratne, K., Natarajan, J. (2019). Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet, 145(1), 129-135. doi:10.1002/ijgo.12749

Billingsley, C. C., Kohler, M. F., Creasman, W. T., Madory, J. E., & Young, J. L. (2012). A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report. J Low Genit Tract Dis, 16(2), 145-148. doi:10.1097/LGT.0b013e3182350490

Bipat, S., Glas, A. S., van der Velden, J., Zwinderman, A. H., Bossuyt, P. M., & Stoker, J. (2003). Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol, 91(1), 59-66.

Bjurberg, M., Holmberg, E., Borgfeldt, C., Floter-Radestad, A., Dahm-Kahler, P., Hjerpe, E., Avall-Lundqvist, E. (2019). Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study. Gynecol Oncol, 155(2), 229-236. doi:10.1016/j.ygyno.2019.08.022

Bjurberg, M., Kjellen, E., Ohlsson, T., Bendahl, P. O., & Brun, E. (2009). Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer. Int J Gynecol Cancer, 19(9), 1600-1605. doi:10.1111/IGC.0b013e3181c00359

Blecharz, P., Reinfuss, M., Jakubowicz, J., Skotnicki, P., Walasek, T., & Luczynska, E. (2013). Effectiveness of radiotherapy in patients with primary invasive vaginal carcinoma. Eur J Gynaecol Oncol, 34(5), 436-441.

Blommaert, J., Zink, R., Deprez, S., Myatchin, I., Dupont, P., Vandenbroucke, T., Lagae, L. (2019). Long-term impact of prenatal exposure to chemotherapy on executive functioning: An ERP study. Clin Neurophysiol, 130(9), 1655-1664. doi:10.1016/j.clinph.2019.06.012

Bodurka-Bevers, D., Morris, M., Eifel, P. J., Levenback, C., Bevers, M. W., Lucas, K. R., & Wharton, J. T. (2000). Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol, 78(2), 187-193. doi:10.1006/gyno.2000.5860

Boere, I., Lok, C., Vandenbroucke, T., & Amant, F. (2017). Cancer in pregnancy: safety and efficacy of systemic therapies. Curr Opin Oncol, 29(5), 328-334. doi:10.1097/cco.0000000000000386

Bondar, M. L., Hoogeman, M. S., Mens, J. W., Quint, S., Ahmad, R., Dhawtal, G., & Heijmen, B. J. (2012). Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans. Int J Radiat Oncol Biol Phys, 83(5), 1617-1623. doi:10.1016/j.ijrobp.2011.10.011

Brinton, L. A., Nasca, P. C., Mallin, K., Schairer, C., Rosenthal, J., Rothenberg, R., Richart, R. M. (1990). Case-control study of in situ and invasive carcinoma of the vagina. Gynecol Oncol, 38(1), 49-54.

Broberg, G., Gyrd-Hansen, D., Miao Jonasson, J., Ryd, M. L., Holtenman, M., Milsom, I., & Strander, B. (2014). Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer, 134(9), 2223-2230. doi:10.1002/ijc.28545

Brunner, A. H., Grimm, C., Polterauer, S., Hefler, L., Stani, J., Heinze, G., & Horvat, R. (2011). The prognostic role of human papillomavirus in patients with vaginal cancer. Int J Gynecol Cancer, 21(5), 923-929. doi:10.1097/IGC.0b013e31821bc615

Burghardt, E., Hofmann, H. M., Ebner, F., Haas, J., Tamussino, K., & Justich, E. (1989). Magnetic resonance imaging in cervical cancer: a basis for objective classification. Gynecol Oncol, 33(1), 61-67.

Burghardt, E., & Pickel, H. (1978). Local spread and lymph node involvement in cervical cancer. Obstet Gynecol, 52(2), 138-145.

Bush, R. S. (1986). The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys, 12(11), 2047-2050. doi:10.1016/0360-3016(86)90146-x

Cantrell, L. A., Mendivil, A., Gehrig, P. A., & Boggess, J. F. (2010). Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience. Gynecol Oncol, 117(2), 260-265. doi:10.1016/j.ygyno.2010.01.012

Cao, D. Y., Yang, J. X., Wu, X. H., Chen, Y. L., Li, L., Liu, K. J., China Gynecologic Oncology, G. (2013). Comparisons of vaginal and abdominal radical trachelectomy for early-stage cervical cancer: preliminary results of a multi-center research in China. Br J Cancer, 109(11), 2778-2782. doi:10.1038/bjc.2013.656

Cardosi, R. J., Cox, C. S., & Hoffman, M. S. (2002). Postoperative neuropathies after major pelvic surgery. Obstet Gynecol, 100(2), 240-244.

Carter, J., Chi, D. S., Brown, C. L., Abu-Rustum, N. R., Sonoda, Y., Aghajanian, C., Barakat, R. R. (2010). Cancer-related infertility in survivorship. Int J Gynecol Cancer, 20(1), 2-8. doi:10.1111/IGC.0b013e3181bf7d3f

Castellsague, X., Bosch, F. X., & Munoz, N. (2002). Environmental co-factors in HPV carcinogenesis. Virus Res, 89(2), 191-199.

Castellsague, X., Drudis, T., Canadas, M. P., Gonce, A., Ros, R., Perez, J. M., Bosch, F. X. (2009). Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect Dis, 9, 74. doi:10.1186/1471-2334-9-74

Castellsague, X., Munoz, N., Pitisuttithum, P., Ferris, D., Monsonego, J., Ault, K., Saah, A. (2011). End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer, 105(1), 28-37. doi:10.1038/bjc.2011.185

Castle, P. E., Pierz, A., & Stoler, M. H. (2018). A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix. Gynecol Oncol, 148(2), 422-429. doi:10.1016/j.ygyno.2017.12.001

Cella, D. (2015). Bevacizumab and quality of life in advanced cervical cancer. Lancet Oncol, 16(3), 241-243. doi:10.1016/S1470-2045(15)70052-5

Cetina, L., Gonzalez-Enciso, A., Cantu, D., Coronel, J., Perez-Montiel, D., Hinojosa, J., Duenas-Gonzalez, A. (2013). Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients. Ann Oncol, 24(8), 2043-2047. doi:10.1093/annonc/mdt142

Chai, Y., Wang, T., Wang, J., Yang, Y., Gao, Y., Gao, J., Liu, Z. (2014). Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer. BMC Cancer, 14, 63. doi:10.1186/1471-2407-14-63

Chang, T. C., Hsueh, S., Lai, C. H., Tseng, C. J., Lee, K. F., Huang, K. G., Soong, Y. K. (1999). Phase II trial of neoadjuvant chemotherapy in early-stage small cell cervical cancer. Anticancer Drugs, 10(7), 641-646.

Chang, T. C., Lai, C. H., Tseng, C. J., Hsueh, S., Huang, K. G., & Chou, H. H. (1998). Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer, 83(4), 712-718.

Chemoradiotherapy for Cervical Cancer Meta-Analysis, C. (2008). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol, 26(35), 5802-5812. doi:10.1200/JCO.2008.16.4368

Chen, A. M., Chen, L. M., Vaughan, A., Sreeraman, R., Farwell, D. G., Luu, Q., Vijayakumar, S. (2011). Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys, 79(2), 414-419. doi:10.1016/j.ijrobp.2009.10.050

Chiantera, V., Rossi, M., De Iaco, P., Koehler, C., Marnitz, S., Ferrandina, G., Vercellino, G. F. (2014). Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. Int J Gynecol Cancer, 24(5), 916-922. doi:10.1097/IGC.0b013e3182a80aec

Choi, H. J., Ju, W., Myung, S. K., & Kim, Y. (2010). Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci, 101(6), 1471-1479. doi:10.1111/j.1349-7006.2010.01532.x

Chu, Y., Zheng, A., Wang, F., Lin, W., Yang, X., Han, L., Bai, L. (2014). Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis. Nucl Med Commun, 35(2), 144-150. doi:10.1097/MNM.0000000000000026

Chung, H. C., Ros, W., Delord, J. P., Perets, R., Italiano, A., Shapira-Frommer, R., Leary, A. (2019). Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study. J Clin Oncol, 37(17), 1470-1478. doi:10.1200/jco.18.01265

Chung, H. H., Lee, I., Kim, H. S., Kim, J. W., Park, N. H., Song, Y. S., & Cheon, G. J. (2013). Prognostic value of preoperative metabolic tumor volume measured by (1)(8)F-FDG PET/CT and MRI in patients with endometrial cancer. Gynecol Oncol, 130(3), 446-451. doi:10.1016/j.ygyno.2013.06.021

Chyle, V., Zagars, G. K., Wheeler, J. A., Wharton, J. T., & Delclos, L. (1996). Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys, 35(5), 891-905.

Cibula, D., Abu-Rustum, N. R., Dusek, L., Slama, J., Zikan, M., Zaal, A., Zweemer, R. P. (2012). Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis. Gynecol Oncol, 127(3), 462-466. doi:10.1016/j.ygyno.2012.08.035

Cibula, D., Abu-Rustum, N. R., Dusek, L., Zikan, M., Zaal, A., Sevcik, L., Zweemer, R. P. (2012). Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol, 124(3), 496-501. doi:10.1016/j.ygyno.2011.11.037

Cibula, D., & McCluggage, W. G. (2019). Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. Gynecol Oncol, 152(1), 202-207. doi:10.1016/j.ygyno.2018.10.007

Cibula, D., Velechovska, P., Slama, J., Fischerova, D., Pinkavova, I., Pavlista, D., Zikan, M. (2010). Late morbidity following nerve-sparing radical hysterectomy. Gynecol Oncol, 116(3), 506-511. doi:10.1016/j.ygyno.2009.10.061

Cobby, M., Browning, J., Jones, A., Whipp, E., & Goddard, P. (1990). Magnetic resonance imaging, computed tomography and endosonography in the local staging of carcinoma of the cervix. Br J Radiol, 63(753), 673-679. doi:10.1259/0007-1285-63-753-673

Coker, A. L., Hopenhayn, C., DeSimone, C. P., Bush, H. M., & Crofford, L. (2009). Violence against Women Raises Risk of Cervical Cancer. J Womens Health (Larchmt), 18(8), 1179-1185. doi:10.1089/jwh.2008.1048

Colombo, N., Carinelli, S., Colombo, A., Marini, C., Rollo, D., Sessa, C., & Group, E. G. W. (2012). Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 23 Suppl 7, vii27-32. doi:10.1093/annonc/mds268

Covens, A., Rosen, B., Murphy, J., Laframboise, S., DePetrillo, A. D., Lickrish, G., Shaw, P. (2002). How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol, 84(1), 145-149. doi:10.1006/gyno.2001.6493

Crafton, S. M., & Salani, R. (2016). Beyond Chemotherapy: An Overview and Review of Targeted Therapy in Cervical Cancer. Clin Ther, 38(3), 449-458. doi:10.1016/j.clinthera.2016.02.007

Creasman, W. T., & Kohler, M. F. (2004). Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol, 92(2), 525-529. doi:10.1016/j.ygyno.2003.11.020

Creasman, W. T., Phillips, J. L., & Menck, H. R. (1998). The National Cancer Data Base report on cancer of the vagina. Cancer, 83(5), 1033-1040.

Cullen, K., Fergus, K., Dasgupta, T., Fitch, M., Doyle, C., & Adams, L. (2012). From "sex toy" to intrusive imposition: a qualitative examination of women's experiences with vaginal dilator use following treatment for gynecological cancer. J Sex Med, 9(4), 1162-1173. doi:10.1111/j.1743-6109.2011.02639.x

Dabi, Y., Simon, V., Carcopino, X., Bendifallah, S., Ouldamer, L., Lavoue, V., Touboul, C. (2018). Therapeutic value of surgical paraaortic staging in locally advanced cervical cancer: a multicenter cohort analysis from the FRANCOGYN study group. J Transl Med, 16(1), 326. doi:10.1186/s12967-018-1703-4

Dahl, L., Wittrup, I., Petersen, L. K., Blaakaer, J., & Vaeggemose, U. (2015). Paradoxes of follow-up - health professionals' views on follow-up after surgical treatment in gynecological cancer. Acta Oncol, 54(2), 194-199. doi:10.3109/0284186X.2014.935475

Daling, J. R., Madeleine, M. M., Schwartz, S. M., Shera, K. A., Carter, J. J., McKnight, B., Tamimi, H. (2002). A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol, 84(2), 263-270. doi:10.1006/gyno.2001.6502

Dalrymple, J. L., Russell, A. H., Lee, S. W., Scudder, S. A., Leiserowitz, G. S., Kinney, W. K., & Smith, L. H. (2004). Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer, 14(1), 110-117.

Damast, S., Takiar, V., McCarthy, S., & Higgins, S. A. (2016). Treatment of early stage vaginal cancer with EBRT and MRI-based intracavitary brachytherapy: A retrospective case review. Gynecol Oncol Rep, 17, 89-92. doi:10.1016/j.gore.2016.08.002

Dargent, D., Franzosi, F., Ansquer, Y., Martin, X., Mathevet, P., & Adeline, P. (2002). [Extended trachelectomy relapse: plea for patient involvement in the medical decision]. Bull Cancer, 89(12), 1027-1030.

Dargent, D., & Mathevet, P. (1995). Schauta's vaginal hysterectomy combined with laparoscopic lymphadenectomy. Baillieres Clin Obstet Gynaecol, 9(4), 691-705.

Darlin, L., Borgfeldt, C., Widen, E., & Kannisto, P. (2014). Elderly women above screening age diagnosed with cervical cancer have a worse prognosis. Anticancer Res, 34(9), 5147-5151.

Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., Members of, L. P. W. G. (2012). The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med, 136(10), 1266-1297. doi:10.5858/arpa.LGT200570

Davis, K. P., Stanhope, C. R., Garton, G. R., Atkinson, E. J., & O'Brien, P. C. (1991). Invasive vaginal carcinoma: analysis of early-stage disease. Gynecol Oncol, 42(2), 131-136.

de Boer, P., Adam, J. A., Buist, M. R., van de Vijver, M. J., Rasch, C. R., Stoker, J., Stalpers, L. J. (2013). Role of MRI in detecting involvement of the uterine internal os in uterine cervical cancer: systematic review of diagnostic test accuracy. Eur J Radiol, 82(9), e422-428. doi:10.1016/j.ejrad.2013.04.027

de Bono, J. S., Concin, N., Hong, D. S., Thistlethwaite, F. C., Machiels, J. P., Arkenau, H. T., Lassen, U. (2019). Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial. Lancet Oncol, 20(3), 383-393. doi:10.1016/s1470-2045(18)30859-3

de Crevoisier, R., Sanfilippo, N., Gerbaulet, A., Morice, P., Pomel, C., Castaigne, D., Haie-meder, C. (2007). Exclusive radiotherapy for primary squamous cell carcinoma of the vagina. Radiother Oncol, 85(3), 362-370. doi:10.1016/j.radonc.2007.09.015

de Haan, J., Verheecke, M., Van Calsteren, K., Van Calster, B., Shmakov, R. G., Mhallem Gziri, M., Amant, F. (2018). Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol, 19(3), 337-346. doi:10.1016/s1470-2045(18)30059-7

de Hullu, J. A., Pras, E., Hollema, H., van der Zee, A. G., Bogchelman, D. H., & Mourits, M. J. (2005). Presentations of endometrial activity after curative radiotherapy for cervical cancer. Maturitas, 51(2), 172-176. doi:10.1016/j.maturitas.2004.07.005

de la Torre, M. (2018). Neoadjuvant chemotherapy in woman with early or locally advanced cervical cancer. Rep Pract Oncol Radiother, 23(6), 528-532. doi:10.1016/j.rpor.2018.09.005

de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Group, H. P. V. T. T. S. (2010). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 11(11), 1048-1056. doi:10.1016/S1470-2045(10)70230-8

De Vuyst, H., Clifford, G. M., Nascimento, M. C., Madeleine, M. M., & Franceschi, S. (2009). Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer, 124(7), 1626-1636. doi:10.1002/ijc.24116

Dean, A. (2001). The palliative effects of octreotide in cancer patients. Chemotherapy, 47 Suppl 2, 54-61. doi:49161

Delgado, G., Bundy, B., Zaino, R., Sevin, B. U., Creasman, W. T., & Major, F. (1990). Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 38(3), 352-357.

Denny, L., Quinn, M., & Hacker, N. (2012). FIGO Cancer Report 2012. Int J Gynaecol Obstet, 119 Suppl 2, S89. doi:10.1016/S0020-7292(12)00458-4

Di Donato, V., Bellati, F., Fischetti, M., Plotti, F., Perniola, G., & Panici, P. B. (2012). Vaginal cancer. Crit Rev Oncol Hematol, 81(3), 286-295. doi:10.1016/j.critrevonc.2011.04.004

Dillner, J., Sparen, P., Andrae, B., & Strander, B. (2018). [Cervical cancer has increased in Sweden in women who had a normal cell sample]. Lakartidningen, 115.

Dimopoulos, J. C., Kirisits, C., Petric, P., Georg, P., Lang, S., Berger, D., & Potter, R. (2006). The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys, 66(1), 83-90. doi:10.1016/j.ijrobp.2006.04.041

Dimopoulos, J. C., Lang, S., Kirisits, C., Fidarova, E. F., Berger, D., Georg, P., Potter, R. (2009). Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys, 75(1), 56-63. doi:10.1016/j.ijrobp.2008.10.033

Dimopoulos, J. C., Petrow, P., Tanderup, K., Petric, P., Berger, D., Kirisits, C., Potter, R. (2012). Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol, 103(1), 113-122. doi:10.1016/j.radonc.2011.12.024

Dimopoulos, J. C., Schmid, M. P., Fidarova, E., Berger, D., Kirisits, C., & Potter, R. (2012). Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. Int J Radiat Oncol Biol Phys, 82(5), 1880-1888. doi:10.1016/j.ijrobp.2011.03.049

Diver, E. J., Rauh-Hain, J. A., & Del Carmen, M. G. (2012). Total pelvic exenteration for gynecologic malignancies. Int J Surg Oncol, 2012, 693535. doi:10.1155/2012/693535

Donati, O. F., Lakhman, Y., Sala, E., Burger, I. A., Vargas, H. A., Goldman, D. A., Hricak, H. (2013). Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration. Eur Radiol, 23(10), 2906-2915. doi:10.1007/s00330-013-2875-1

Dostalek, L., Zikan, M., Fischerova, D., Kocian, R., Germanova, A., Fruhauf, F., Cibula, D. (2018). SLN biopsy in cervical cancer patients with tumors larger than 2cm and 4cm. Gynecol Oncol, 148(3), 456-460. doi:10.1016/j.ygyno.2018.01.001

Drescher, C. W., Hopkins, M. P., & Roberts, J. A. (1989). Comparison of the pattern of metastatic spread of squamous cell cancer and adenocarcinoma of the uterine cervix. Gynecol Oncol, 33(3), 340-343.

Dunberger, G., & Bergmark, K. (2012). Nurse-led care for the management of side effects of pelvic radiotherapy: what does it achieve? Curr Opin Support Palliat Care, 6(1), 60-68. doi:10.1097/SPC.0b013e32834f6a95

Dunberger, G., Lindquist, H., Waldenstrom, A. C., Nyberg, T., Steineck, G., & Avall-Lundqvist, E. (2013). Lower limb lymphedema in gynecological cancer survivors--effect on daily life functioning. Support Care Cancer, 21(11), 3063-3070. doi:10.1007/s00520-013-1879-3

Dunst, J., Kuhnt, T., Strauss, H. G., Krause, U., Pelz, T., Koelbl, H., & Haensgen, G. (2003). Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys, 56(3), 778-787.

Duyn, A., Van Eijkeren, M., Kenter, G., Zwinderman, K., & Ansink, A. (2002). Recurrent cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand, 81(8), 759-763.

Eifel, P. J., Winter, K., Morris, M., Levenback, C., Grigsby, P. W., Cooper, J., Mutch, D. G. (2004). Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol, 22(5), 872-880. doi:10.1200/JCO.2004.07.197

Eisen, A. F., Atkinson, M. J., Celler, J. W., Paige, C. J., & Wu, G. E. (1991). Measurement of recombinase activity in a set of related Abelson murine leukemic virus pre-B cell lines: DJ/DJ lines have more recombinase activity than do VDJ/VDJ lines. Int Immunol, 3(5), 477-484. doi:10.1093/intimm/3.5.477

Elfgren, K., Jacobs, M., Walboomers, J. M., Meijer, C. J., & Dillner, J. (2002). Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia. Obstet Gynecol, 100(5 Pt 1), 965-971.

Elit, L., Fyles, A. W., Devries, M. C., Oliver, T. K., Fung-Kee-Fung, M., & Gynecology Cancer Disease Site, G. (2009). Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol, 114(3), 528-535. doi:10.1016/j.ygyno.2009.06.001

Emami, B., Lyman, J., Brown, A., Coia, L., Goitein, M., Munzenrider, J. E., Wesson, M. (1991). Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 21(1), 109-122.

Embry, J. R., Kelly, M. G., Post, M. D., & Spillman, M. A. (2011). Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy. Gynecol Oncol, 120(3), 444-448. doi:10.1016/j.ygyno.2010.11.007

Epstein, E., Di Legge, A., Masback, A., Lindqvist, P. G., Kannisto, P., & Testa, A. C. (2010). Sonographic characteristics of squamous cell cancer and adenocarcinoma of the uterine cervix. Ultrasound Obstet Gynecol, 36(4), 512-516. doi:10.1002/uog.7638

Epstein, E., Testa, A., Gaurilcikas, A., Di Legge, A., Ameye, L., Atstupenaite, V., Fischerova, D. (2013). Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial. Gynecol Oncol, 128(3), 449-453. doi:10.1016/j.ygyno.2012.09.025

Eriksson, L. S., Lindqvist, P. G., Floter Radestad, A., Dueholm, M., Fischerova, D., Franchi, D., Epstein, E. (2015). Transvaginal ultrasound assessment of myometrial and cervical stromal invasion in women with endometrial cancer: interobserver reproducibility among ultrasound experts and gynecologists. Ultrasound Obstet Gynecol, 45(4), 476-482. doi:10.1002/uog.14645

Estape, R. E., Angioli, R., Madrigal, M., Janicek, M., Gomez, C., Penalver, M., & Averette, H. (1998). Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol Oncol, 68(3), 229-232. doi:10.1006/gyno.1998.4960

Evander, M., Edlund, K., Gustafsson, A., Jonsson, M., Karlsson, R., Rylander, E., & Wadell, G. (1995). Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis, 171(4), 1026-1030.

Evans, J. C., & Bergsjo, P. (1965). THE INFLUENCE OF ANEMIA ON THE RESULTS OF RADIOTHERAPY IN CARCINOMA OF THE CERVIX. Radiology, 84, 709-717. doi:10.1148/84.4.709

Everhov, A. H., Floter Radestad, A., Nyberg, T., Smedby, K. E., Bergmark, K., & Linden Hirschberg, A. (2016). Serum Androgen Levels and Sexual Function Before and One Year After Treatment of Uterine Cervical Cancer: A Pilot Study. J Sex Med, 13(3), 413-424. doi:10.1016/j.jsxm.2015.12.022

Falcone, T., Attaran, M., Bedaiwy, M. A., & Goldberg, J. M. (2004). Ovarian function preservation in the cancer patient. Fertil Steril, 81(2), 243-257. doi:10.1016/j.fertnstert.2003.06.031

Falconer, H., Palsdottir, K., Stalberg, K., Dahm-Kahler, P., Ottander, U., Lundin, E. S., Salehi, S. (2019). Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial. Int J Gynecol Cancer, 29(6), 1072-1076. doi:10.1136/ijgc-2019-000558

Feeney, D. D., Moore, D. H., Look, K. Y., Stehman, F. B., & Sutton, G. P. (1995). The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol, 56(1), 3-7. doi:10.1006/gyno.1995.1002

Feldbaum, V. M., Flowers, L. C., & Oprea-Ilies, G. M. (2014). Improved survival in p16-positive vaginal cancers across all tumor stages but no correlation with MIB-1. Am J Clin Pathol, 142(5), 664-669. doi:10.1309/AJCPMG0XIF7PEISO

Ferrandina, G., Mantegna, G., Petrillo, M., Fuoco, G., Venditti, L., Terzano, S., Scambia, G. (2012). Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study. Gynecol Oncol, 124(3), 389-394. doi:10.1016/j.ygyno.2011.09.041

Fiorino, C., Valdagni, R., Rancati, T., & Sanguineti, G. (2009). Dose-volume effects for normal tissues in external radiotherapy: pelvis. Radiother Oncol, 93(2), 153-167. doi:10.1016/j.radonc.2009.08.004

Fischerova, D. (2011). Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review. Ultrasound Obstet Gynecol, 38(3), 246-266. doi:10.1002/uog.10054

Fischerova, D., Cibula, D., Stenhova, H., Vondrichova, H., Calda, P., Zikan, M., Belacek, J. (2008). Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer. Int J Gynecol Cancer, 18(4), 766-772. doi:10.1111/j.1525-1438.2007.01072.x

Folkhälsomyndigheten. (2007). Background to a vaccination programme for the human papilloma virus in Sweden 2007 Retrieved from https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/b/background-to-a-vaccination-programme-for-the-human-papilloma-virus-in-sweden-2007/

https://www.folkhalsomyndigheten.se/contentassets/fec148272e0d40a2a172fb9ab5ebb5fc/background-to-a-vaccination-programme-for-the-human-papilloma-virus-in-sweden-2007-2008-132-2.pdf

Frank, S. J., Jhingran, A., Levenback, C., & Eifel, P. J. (2005). Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys, 62(1), 138-147. doi:10.1016/j.ijrobp.2004.09.032

Fridsten, S., Hellstrom, A. C., Hellman, K., Sundin, A., Soderen, B., & Blomqvist, L. (2016). Preoperative MR staging of cervical carcinoma: are oblique and contrast-enhanced sequences necessary? Acta Radiol Open, 5(11), 2058460116679460. doi:10.1177/2058460116679460

Friedlander, M., Grogan, M., & Force, U. S. P. S. T. (2002). Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist, 7(4), 342-347.

Frumovitz, M., dos Reis, R., Sun, C. C., Milam, M. R., Bevers, M. W., Brown, J., Ramirez, P. T. (2007). Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstet Gynecol, 110(1), 96-102. doi:10.1097/01.AOG.0000268798.75353.04

Frumovitz, M., Munsell, M. F., Burzawa, J. K., Byers, L. A., Ramalingam, P., Brown, J., & Coleman, R. L. (2017). Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. Gynecol Oncol, 144(1), 46-50. doi:10.1016/j.ygyno.2016.10.040

Frumovitz, M., Plante, M., Lee, P. S., Sandadi, S., Lilja, J. F., Escobar, P. F., Abu-Rustum, N. R. (2018). Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol, 19(10), 1394-1403. doi:10.1016/s1470-2045(18)30448-0

Fuller, A. F., Jr., Elliott, N., Kosloff, C., Hoskins, W. J., & Lewis, J. L., Jr. (1989). Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol, 33(1), 34-39.

Fuller, J., Guderian, D., Kohler, C., Schneider, A., & Wendt, T. G. (2008). Lymph edema of the lower extremities after lymphadenectomy and radiotherapy for cervical cancer. Strahlenther Onkol, 184(4), 206-211. doi:10.1007/s00066-008-1728-3

Future Ii Study Group. (2007a). Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. J Infect Dis, 196(10), 1438-1446. doi:10.1086/522864

Future Ii Study Group. (2007b). Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med, 356(19), 1915-1927. doi:10.1056/NEJMoa061741

Fyles, A., Keane, T. J., Barton, M., & Simm, J. (1992). The effect of treatment duration in the local control of cervix cancer. Radiother Oncol, 25(4), 273-279.

Gadducci, A., Fabrini, M. G., Lanfredini, N., & Sergiampietri, C. (2015). Squamous cell carcinoma of the vagina: natural history, treatment modalities and prognostic factors. Crit Rev Oncol Hematol, 93(3), 211-224. doi:10.1016/j.critrevonc.2014.09.002

Gardner, C. S., Sunil, J., Klopp, A. H., Devine, C. E., Sagebiel, T., Viswanathan, C., & Bhosale, P. R. (2015). Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. Br J Radiol, 88(1052), 20150033. doi:10.1259/bjr.20150033

Gardner, G. J., Reidy-Lagunes, D., & Gehrig, P. A. (2011). Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol, 122(1), 190-198. doi:10.1016/j.ygyno.2011.04.011

Garland, S. M., Joura, E. A., Ault, K. A., Bosch, F. X., Brown, D. R., Castellsague, X., Velicer, C. (2018). Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age. Obstet Gynecol, 132(2), 261-270. doi:10.1097/aog.0000000000002736

Gatcliffe, T. A., & Coleman, R. L. (2008). Tumor board: more than treatment planning--a 1-year prospective survey. J Cancer Educ, 23(4), 235-237. doi:10.1080/08858190802189014

Geijteman, E. C., Wensveen, C. W., Duvekot, J. J., & van Zuylen, L. (2014). A child with severe hearing loss associated with maternal cisplatin treatment during pregnancy. Obstet Gynecol, 124(2 Pt 2 Suppl 1), 454-456. doi:10.1097/aog.0000000000000389

Gemer, O., Lavie, O., Gdalevich, M., Eitan, R., Mamanov, E., Piura, B., Arie, A. B. (2016). Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer. Am J Clin Oncol, 39(1), 37-42. doi:10.1097/coc.0000000000000011

Gilks, C. B., Young, R. H., Gersell, D. J., & Clement, P. B. (1997). Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases. Am J Surg Pathol, 21(8), 905-914.

Giuliano, A. R., Lee, J. H., Fulp, W., Villa, L. L., Lazcano, E., Papenfuss, M. R., Smith, D. (2011). Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet, 377(9769), 932-940. doi:10.1016/s0140-6736(10)62342-2

Gondi, V., Bentzen, S. M., Sklenar, K. L., Dunn, E. F., Petereit, D. G., Tannehill, S. P., Bradley, K. A. (2012). Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis. Int J Radiat Oncol Biol Phys, 84(4), 973-982. doi:10.1016/j.ijrobp.2012.01.064

Green, J., Kirwan, J., Tierney, J., Vale, C., Symonds, P., Fresco, L., Collingwood, M. (2005). Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev(3), CD002225. doi:10.1002/14651858.CD002225.pub2

Greer, H. O., Frederick, P. J., Falls, N. M., Tapley, E. B., Samples, K. L., Kimball, K. J., Straughn, J. M., Jr. (2010). Impact of a weekly multidisciplinary tumor board conference on the management of women with gynecologic malignancies. Int J Gynecol Cancer, 20(8), 1321-1325. doi:10.1111/IGC.0b013e3181f5871e

Grigsby, P. W. (2002). Vaginal cancer. Curr Treat Options Oncol, 3(2), 125-130.

Grisaru, D., Covens, A., Chapman, B., Shaw, P., Colgan, T., Murphy, J., Rosen, B. (2001). Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer, 92(12), 2999-3004.

Grogan, M., Thomas, G. M., Melamed, I., Wong, F. L., Pearcey, R. G., Joseph, P. K., Jones, K. D. (1999). The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer, 86(8), 1528-1536.

Guitarte, C., Alagkiozidis, I., Mize, B., Stevens, E., Salame, G., & Lee, Y. C. (2014). Glassy cell carcinoma of the cervix: a systematic review and meta-analysis. Gynecol Oncol, 133(2), 186-191. doi:10.1016/j.ygyno.2014.01.048

Gunderson, C. C., Nugent, E. K., Yunker, A. C., Rocconi, R. P., Graybill, W. S., Erickson, B. K., & Moore, K. N. (2013). Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis, 17(4), 409-413. doi:10.1097/LGT.0b013e3182800ee2

Gupta, S., Maheshwari, A., Parab, P., Mahantshetty, U., Hawaldar, R., Sastri Chopra, S., Badwe, R. (2018). Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. J Clin Oncol, 36(16), 1548-1555. doi:10.1200/jco.2017.75.9985

Gustafsson, L., & Adami, H. O. (1989). Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer, 60(1), 132-141.

Hacker, N. F., Eifel, P. J., & van der Velden, J. (2012). Cancer of the vagina. Int J Gynaecol Obstet, 119 Suppl 2, S97-99. doi:10.1016/S0020-7292(12)60022-8

Haie-Meder, C., Chargari, C., Rey, A., Dumas, I., Morice, P., & Magne, N. (2010). MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol, 96(2), 161-165. doi:10.1016/j.radonc.2010.04.015

Haie-Meder, C., Potter, R., Van Limbergen, E., Briot, E., De Brabandere, M., Dimopoulos, J., Gynaecological, G. E. C. E. W. G. (2005). Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol, 74(3), 235-245. doi:10.1016/j.radonc.2004.12.015

Hannoun-Levi, J. M., Peiffert, D., Hoffstetter, S., Luporsi, E., Bey, P., & Pernot, M. (1997). Carcinoma of the cervical stump: retrospective analysis of 77 cases. Radiother Oncol, 43(2), 147-153.

Hareyama, H., Hada, K., Goto, K., Watanabe, S., Hakoyama, M., Oku, K., Okuyama, K. (2015). Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies: a retrospective study. Int J Gynecol Cancer, 25(4), 751-757. doi:10.1097/IGC.0000000000000405

Hasselle, M. D., Rose, B. S., Kochanski, J. D., Nath, S. K., Bafana, R., Yashar, C. M., Mell, L. K. (2011). Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys, 80(5), 1436-1445. doi:10.1016/j.ijrobp.2010.04.041

Havrilesky, L. J., Kulasingam, S. L., Matchar, D. B., & Myers, E. R. (2005). FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol, 97(1), 183-191. doi:10.1016/j.ygyno.2004.12.007

Heard, I. (2009). Prevention of cervical cancer in women with HIV. Curr Opin HIV AIDS, 4(1), 68-73. doi:10.1097/COH.0b013e328319bcbe

Heijkoop, S. T., Langerak, T. R., Quint, S., Bondar, L., Mens, J. W., Heijmen, B. J., & Hoogeman, M. S. (2014). Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT. Int J Radiat Oncol Biol Phys, 90(3), 673-679. doi:10.1016/j.ijrobp.2014.06.046

Hellbom, M., & Thomé, B. (2013). Mötet kring existentiella frågor. In Rehabilitering vid cancersjukdom. Att möta framtiden (pp. 210-). Stockholm: Natur och Kultur.

Hellebust, T. P., Kirisits, C., Berger, D., Perez-Calatayud, J., De Brabandere, M., De Leeuw, A., Gynaecological, G. E. C. E. W. G. (2010). Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol, 96(2), 153-160. doi:10.1016/j.radonc.2010.06.004

Hellman, K., Alaiya, A. A., Becker, S., Lomnytska, M., Schedvins, K., Steinberg, W., Auer, G. (2009). Differential tissue-specific protein markers of vaginal carcinoma. Br J Cancer, 100(8), 1303-1314. doi:10.1038/sj.bjc.6604975

Hellman, K., & Frankendal, B. Molecular markers of malignant tumours of the vagina. In CME Journal of Gynecologic Oncology. Syrjänen KJ. Budapest: NOK Press 2006-11, 1, pp 23-29.

Hellman, K., Lindquist, D., Ranhem, C., Wilander, E., & Andersson, S. (2014). Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina. Br J Cancer, 110(6), 1561-1570. doi:10.1038/bjc.2014.32

Hellman, K., Lundell, M., Silfversward, C., Nilsson, B., Hellstrom, A. C., & Frankendal, B. (2006). Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina. Int J Gynecol Cancer, 16(3), 1201-1211. doi:10.1111/j.1525-1438.2006.00520.x

Hellman, K., Silfversward, C., Nilsson, B., Hellstrom, A. C., Frankendal, B., & Pettersson, F. (2004). Primary carcinoma of the vagina: factors influencing the age at diagnosis. The Radiumhemmet series 1956-96. Int J Gynecol Cancer, 14(3), 491-501. doi:10.1111/j.1048-891x.2004.014310.x

Hellstrom, A. C., Hellman, K., Pettersson, B. F., & Andersson, S. (2011). Carcinoma of the cervical stump: fifty years of experience. Oncol Rep, 25(6), 1651-1654. doi:10.3892/or.2011.1228

Hellstrom, A. C., Sigurjonson, T., & Pettersson, F. (2001). Carcinoma of the cervical stump. The radiumhemmet series 1959-1987. Treatment and prognosis. Acta Obstet Gynecol Scand, 80(2), 152-157.

Henson, D., & Tarone, R. (1977). An epidemiologic study of cancer of the cervix, vagina, and vulva based on the Third National Cancer Survey in the United States. Am J Obstet Gynecol, 129(5), 525-532.

Hequet, D., Marchand, E., Place, V., Fourchotte, V., De La Rochefordiere, A., Dridi, S., Barranger, E. (2013). Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter study. Eur J Surg Oncol, 39(12), 1428-1434. doi:10.1016/j.ejso.2013.10.006

Herman, J. M., Homesley, H. D., & Dignan, M. B. (1986). Is hysterectomy a risk factor for vaginal cancer? JAMA, 256(5), 601-603.

Hertel, H., Soergel, P., Muecke, J., Schneider, M., Papendorf, F., Laenger, F., Hillemanns, P. (2013). Is there a place for sentinel technique in treatment of vaginal cancer?: feasibility, clinical experience, and results. Int J Gynecol Cancer, 23(9), 1692-1698. doi:10.1097/IGC.0b013e3182a65455

Hildesheim, A., Han, C.-L., Brinton, L. A., Nasca, P. C., Richart, R. M., Jones, R. B., Schiller, J. T. (1997). Sexually transmitted agents and risk of carcinoma of the vagina. 7(4), 251-255. doi:10.1046/j.1525-1438.1997.00462.x

Hinds, L., & Price, J. (2010). Menopause, hormone replacement and gynaecological cancers. Menopause Int, 16(2), 89-93. doi:10.1258/mi.2010.010018

Hiniker, S. M., Roux, A., Murphy, J. D., Harris, J. P., Tran, P. T., Kapp, D. S., & Kidd, E. A. (2013). Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes. Gynecol Oncol, 131(2), 380-385. doi:10.1016/j.ygyno.2013.08.012

Hintz, B. L., Kagan, A. R., Chan, P., Gilbert, H. A., Nussbaum, H., Rao, A. R., & Wollin, M. (1980). Radiation tolerance of the vaginal mucosa. Int J Radiat Oncol Biol Phys, 6(6), 711-716.

Hoff, C. M., Grau, C., & Overgaard, J. (2012). Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study. Radiother Oncol, 103(1), 38-44. doi:10.1016/j.radonc.2012.01.011

Hofsjo, A., Bergmark, K., Blomgren, B., Jahren, H., & Bohm-Starke, N. (2018). Radiotherapy for cervical cancer - impact on the vaginal epithelium and sexual function. Acta Oncol, 57(3), 338-345. doi:10.1080/0284186x.2017.1400684

Hofsjo, A., Bohm-Starke, N., Blomgren, B., Jahren, H., Steineck, G., & Bergmark, K. (2017). Radiotherapy-induced vaginal fibrosis in cervical cancer survivors. Acta Oncol, 56(5), 661-666. doi:10.1080/0284186x.2016.1275778

Hope, J. M., & Pothuri, B. (2013). The role of palliative surgery in gynecologic cancer cases. Oncologist, 18(1), 73-79. doi:10.1634/theoncologist.2012-0328

Horn, L. C., Bilek, K., Fischer, U., Einenkel, J., & Hentschel, B. (2014). A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer. Gynecol Oncol, 134(1), 42-46. doi:10.1016/j.ygyno.2014.04.011

Horn, L. C., Fischer, U., Raptis, G., Bilek, K., & Hentschel, B. (2007). Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol, 107(2), 310-315. doi:10.1016/j.ygyno.2007.06.026

Horn, L. C., Hentschel, B., Galle, D., & Bilek, K. (2008). Extracapsular extension of pelvic lymph node metastases is of prognostic value in carcinoma of the cervix uteri. Gynecol Oncol, 108(1), 63-67. doi:10.1016/j.ygyno.2007.08.086

Horn, L. C., Meinel, A., Handzel, R., & Einenkel, J. (2007). Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Ann Diagn Pathol, 11(4), 297-311. doi:10.1016/j.anndiagpath.2007.05.002

Horvath, L. E., Yordan, E., Malhotra, D., Leyva, I., Bortel, K., Schalk, D., Huml, J. (2010). Multidisciplinary care in the oncology setting: historical perspective and data from lung and gynecology multidisciplinary clinics. J Oncol Pract, 6(6), e21-26. doi:10.1200/JOP.2010.000073

Hoskins, P. J., Swenerton, K. D., Pike, J. A., Lim, P., Aquino-Parsons, C., Wong, F., & Lee, N. (2003). Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol, 21(18), 3495-3501. doi:10.1200/JCO.2003.01.501

Houghton, C. R., & Iversen, T. (1982). Squamous cell carcinoma of the vagina: a clinical study of the location of the tumor. Gynecol Oncol, 13(3), 365-372.

Howell, D. D., James, J. L., Hartsell, W. F., Suntharalingam, M., Machtay, M., Suh, J. H., Berk, L. B. (2013). Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14. Cancer, 119(4), 888-896. doi:10.1002/cncr.27616

Hricak, H., Gatsonis, C., Chi, D. S., Amendola, M. A., Brandt, K., Schwartz, L. H., Gynecologic Oncology, G. (2005). Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol, 23(36), 9329-9337. doi:10.1200/JCO.2005.02.0354

Hricak, H., Lacey, C. G., Sandles, L. G., Chang, Y. C., Winkler, M. L., & Stern, J. L. (1988). Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology, 166(3), 623-631. doi:10.1148/radiology.166.3.3340756

Huang, J., Barbera, L., Brouwers, M., Browman, G., & Mackillop, W. J. (2003). Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol, 21(3), 555-563.

Hubbs, J. L., Dickson Michelson, E. L., Vogel, R. I., Rivard, C. L., Teoh, D. G. K., & Geller, M. A. (2019). Sexual quality of life after the treatment of gynecologic cancer: what women want. Support Care Cancer, 27(12), 4649-4654. doi:10.1007/s00520-019-04756-7

Hur, H. C., Donnellan, N., Mansuria, S., Barber, R. E., Guido, R., & Lee, T. (2011). Vaginal cuff dehiscence after different modes of hysterectomy. Obstet Gynecol, 118(4), 794-801. doi:10.1097/AOG.0b013e31822f1c92

Hwang, L., Bailey, A., Lea, J., & Albuquerque, K. (2015). Para-aortic nodal metastases in cervical cancer: a blind spot in the International Federation of Gynecology and Obstetrics staging system: current diagnosis and management. Future Oncol, 11(2), 309-322. doi:10.2217/fon.14.200

Höckel, M., Horn, L. C., Manthey, N., Braumann, U. D., Wolf, U., Teichmann, G., Einenkel, J. (2009). Resection of the embryologically defined uterovaginal (Mullerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol, 10(7), 683-692. doi:10.1016/S1470-2045(09)70100-7

Indraccolo, U., Chiocci, L., & Baldoni, A. (2008). Does vaginal intraepithelial neoplasia have the same evolution as cervical intraepithelial neoplasia? Eur J Gynaecol Oncol, 29(4), 371-373.

Ingles, D. J., Lin, H. Y., Fulp, W. J., Sudenga, S. L., Lu, B., Schabath, M. B., Giuliano, A. R. (2015). An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study. Papillomavirus Res, 1, 126-135. doi:10.1016/j.pvr.2015.09.001

Innocenti, P., Pulli, F., Savino, L., Nicolucci, A., Pandimiglio, A., Menchi, I., & Massi, G. (1992). Staging of cervical cancer: reliability of transrectal US. Radiology, 185(1), 201-205. doi:10.1148/radiology.185.1.1523308

Inoue, T., & Morita, K. (1990). The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer, 65(9), 1923-1927.

Inoue, T., & Okumura, M. (1984). Prognostic significance of parametrial extension in patients with cervical carcinoma Stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation. Cancer, 54(8), 1714-1719.

International Collaboration of Epidemiological Studies of Cervical, C., Appleby, P., Beral, V., Berrington de Gonzalez, A., Colin, D., Franceschi, S., Sweetland, S. (2007). Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet, 370(9599), 1609-1621. doi:10.1016/S0140-6736(07)61684-5

International Collaboration of Epidemiological Studies of Cervical, C., Appleby, P., Beral, V., Berrington de Gonzalez, A., Colin, D., Franceschi, S., Sweetland, S. (2006). Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer, 118(6), 1481-1495. doi:10.1002/ijc.21493

Jadon, R., Pembroke, C. A., Hanna, C. L., Palaniappan, N., Evans, M., Cleves, A. E., & Staffurth, J. (2014). A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer. Clin Oncol (R Coll Radiol), 26(4), 185-196. doi:10.1016/j.clon.2013.11.031

Jager, L., Nilsson, P. J., & Radestad, A. F. (2013). Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution. Int J Gynecol Cancer, 23(4), 755-762. doi:10.1097/IGC.0b013e318287a874

Janelsins, M. C., Kohli, S., Mohile, S. G., Usuki, K., Ahles, T. A., & Morrow, G. R. (2011). An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol, 38(3), 431-438. doi:10.1053/j.seminoncol.2011.03.014

Jang, W. I., Wu, H. G., Ha, S. W., Kim, H. J., Kang, S. B., Song, Y. S., Kim, J. W. (2012). Definitive radiotherapy for treatment of primary vaginal cancer: effectiveness and prognostic factors. Int J Gynecol Cancer, 22(3), 521-527. doi:10.1097/IGC.0b013e31823fd621

Jensen, A. R., Nellemann, H. M., & Overgaard, J. (2007). Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol, 84(1), 5-10. doi:10.1016/j.radonc.2007.04.001

Jensen, L. G., Hasselle, M. D., Rose, B. S., Nath, S. K., Hasan, Y., Scanderbeg, D. J., Mell, L. K. (2013). Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin. Int J Gynecol Cancer, 23(1), 119-125. doi:10.1097/IGC.0b013e3182749114

Johansen, G., Lonnerfors, C., Falconer, H., & Persson, J. (2016). Reproductive and oncologic outcome following robot-assisted laparoscopic radical trachelectomy for early stage cervical cancer. Gynecol Oncol, 141(1), 160-165. doi:10.1016/j.ygyno.2016.01.028

Josephs, S. C. (2008). Obstetric and gynecologic emergencies: a review of indications and interventional techniques. Semin Intervent Radiol, 25(4), 337-346. doi:10.1055/s-0028-1102992

Kaidar-Person, O., Abdah-Bortnyak, R., Amit, A., Nevelsky, A., Berniger, A., Bar-Deroma, R., Kuten, A. (2014). Tolerance of the vaginal vault to high-dose rate brachytherapy and concomitant chemo-pelvic irradiation: Long-term perspective. Rep Pract Oncol Radiother, 19(1), 56-61. doi:10.1016/j.rpor.2013.09.005

Kamura, T., Tsukamoto, N., Tsuruchi, N., Saito, T., Matsuyama, T., Akazawa, K., & Nakano, H. (1992). Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer, 69(1), 181-186.

Kapp, K. S., Poschauko, J., Geyer, E., Berghold, A., Oechs, A. C., Petru, E., Kapp, D. S. (2002). Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys, 54(1), 58-66.

Kasamatsu, T., Onda, T., Sawada, M., Kato, T., Ikeda, S., Sasajima, Y., & Tsuda, H. (2009). Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix. Br J Cancer, 100(9), 1400-1405. doi:10.1038/sj.bjc.6605048

Kato, T., Watari, H., Takeda, M., Hosaka, M., Mitamura, T., Kobayashi, N., Sakuragi, N. (2013). Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy. J Gynecol Oncol, 24(3), 222-228. doi:10.3802/jgo.2013.24.3.222

Kerr-Wilson, R. H., & McCrum, A. (1995). Follow-up of patients with gynaecological cancer. Aust N Z J Obstet Gynaecol, 35(3), 298-299.

Keulers, B. J., Scheltinga, M. R., Houterman, S., Van Der Wilt, G. J., & Spauwen, P. H. (2008). Surgeons underestimate their patients' desire for preoperative information. World J Surg, 32(6), 964-970. doi:10.1007/s00268-008-9581-1

Kew, F. M., Galaal, K., & Manderville, H. (2009). Patients' views of follow-up after treatment for gynaecological cancer. J Obstet Gynaecol, 29(2), 135-142. doi:10.1080/01443610802646801

Kidd, E. A., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2007). The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer, 110(8), 1738-1744. doi:10.1002/cncr.22974

Kidd, E. A., Siegel, B. A., Dehdashti, F., Rader, J. S., Mutic, S., Mutch, D. G., Grigsby, P. W. (2010). Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys, 77(4), 1085-1091. doi:10.1016/j.ijrobp.2009.06.041

Kim, D. H., Lee, J. H., Ki, Y. K., Nam, J. H., Kim, W. T., Jeon, H. S., Kim, D. W. (2013). Short-course palliative radiotherapy for uterine cervical cancer. Radiat Oncol J, 31(4), 216-221. doi:10.3857/roj.2013.31.4.216

Kim, S. H., Choi, B. I., Lee, H. P., Kang, S. B., Choi, Y. M., Han, M. C., & Kim, C. W. (1990). Uterine cervical carcinoma: comparison of CT and MR findings. Radiology, 175(1), 45-51. doi:10.1148/radiology.175.1.2315503

Kim, S. M., Choi, H. S., & Byun, J. S. (2000). Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer, 10(4), 305-312.

Kim, W. Y., Chang, S. J., Chang, K. H., Yoo, S. C., Lee, E. J., & Ryu, H. S. (2011). Reliability of magnetic resonance imaging for bladder or rectum invasion in cervical cancer. J Reprod Med, 56(11-12), 485-490.

Kinney, W. K., Alvarez, R. D., Reid, G. C., Schray, M. F., Soong, S. J., Morley, G. W., Shingleton, H. M. (1989). Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study. Gynecol Oncol, 34(3), 258-262.

Kirchheiner, K., Nout, R. A., Tanderup, K., Lindegaard, J. C., Westerveld, H., Haie-Meder, C., Potter, R. (2014). Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys, 89(1), 88-95. doi:10.1016/j.ijrobp.2014.01.032

Kirkbride, P., Fyles, A., Rawlings, G. A., Manchul, L., Levin, W., Murphy, K. J., & Simm, J. (1995). Carcinoma of the vagina--experience at the Princess Margaret Hospital (1974-1989). Gynecol Oncol, 56(3), 435-443. doi:10.1006/gyno.1995.1077

Kirwan, J. M., Symonds, P., Green, J. A., Tierney, J., Collingwood, M., & Williams, C. J. (2003). A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol, 68(3), 217-226.

Kitagawa, R., Katsumata, N., Shibata, T., Kamura, T., Kasamatsu, T., Nakanishi, T., Yoshikawa, H. (2015). Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505. J Clin Oncol, 33(19), 2129-2135. doi:10.1200/JCO.2014.58.4391

Knight, K. R., Kraemer, D. F., & Neuwelt, E. A. (2005). Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol, 23(34), 8588-8596. doi:10.1200/jco.2004.00.5355

Koh, W. J., Abu-Rustum, N. R., Bean, S., Bradley, K., Campos, S. M., Cho, K. R., Scavone, J. L. (2019). Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(1), 64-84. doi:10.6004/jnccn.2019.0001

Kohler, C., Tozzi, R., Klemm, P., & Schneider, A. (2003). "Schauta sine utero": technique and results of laparoscopic-vaginal radical parametrectomy. Gynecol Oncol, 91(2), 359-368.

Kondo, E., Tabata, T., Shiozaki, T., Motohashi, T., Tanida, K., Okugawa, T., & Ikeda, T. (2013). Large or persistent lymphocyst increases the risk of lymphedema, lymphangitis, and deep vein thrombosis after retroperitoneal lymphadenectomy for gynecologic malignancy. Arch Gynecol Obstet, 288(3), 587-593. doi:10.1007/s00404-013-2769-0

Kruijdenberg, C. B., van den Einden, L. C., Hendriks, J. C., Zusterzeel, P. L., & Bekkers, R. L. (2011). Robot-assisted versus total laparoscopic radical hysterectomy in early cervical cancer, a review. Gynecol Oncol, 120(3), 334-339. doi:10.1016/j.ygyno.2010.12.342

Kucera, H., Langer, M., Smekal, G., & Weghaupt, K. (1985). Radiotherapy of primary carcinoma of the vagina: management and results of different therapy schemes. Gynecol Oncol, 21(1), 87-93.

Kucukmetin, A., Biliatis, I., Naik, R., & Bryant, A. (2013). Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer. Cochrane Database Syst Rev, 10, CD006651. doi:10.1002/14651858.CD006651.pub3

Kupets, R., Thomas, G. M., & Covens, A. (2002). Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecol Oncol, 87(2), 163-170.

Laliscia, C., Gadducci, A., Fabrini, M. G., Barcellini, A., Guerrieri, M. E., Parietti, E., Paiar, F. (2017). Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes. Oncol Res Treat, 40(11), 697-701. doi:10.1159/000480350

Lamoreaux, W. T., Grigsby, P. W., Dehdashti, F., Zoberi, I., Powell, M. A., Gibb, R. K., Siegel, B. A. (2005). FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys, 62(3), 733-737. doi:10.1016/j.ijrobp.2004.12.011

Lanceley, A., Fiander, A., McCormack, M., & Bryant, A. (2013). Follow-up protocols for women with cervical cancer after primary treatment. Cochrane Database Syst Rev, 11, CD008767. doi:10.1002/14651858.CD008767.pub2

Lanciano, R. M., Pajak, T. F., Martz, K., & Hanks, G. E. (1993). The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys, 25(3), 391-397.

Lanciano, R. M., Won, M., Coia, L. R., & Hanks, G. E. (1991). Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys, 20(4), 667-676.

Landoni, F., Maneo, A., Colombo, A., Placa, F., Milani, R., Perego, P., Mangioni, C. (1997). Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet, 350(9077), 535-540. doi:10.1016/S0140-6736(97)02250-2

Landoni, F., Sartori, E., Maggino, T., Zola, P., Zanagnolo, V., Cosio, S., Gadducci, A. (2014). Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study. Gynecol Oncol, 132(3), 611-617. doi:10.1016/j.ygyno.2013.12.010

Lanowska, M., Mangler, M., Grittner, U., Akbar, G. R., Speiser, D., von Tucher, E., Kuhn, W. (2014). Isthmic-vaginal smear cytology in the follow-up after radical vaginal trachelectomy for early stage cervical cancer: is it safe? Cancer Cytopathol, 122(5), 349-358. doi:10.1002/cncy.21402

Lanowska, M., Mangler, M., Spek, A., Grittner, U., Hasenbein, K., Chiantera, V., Speiser, D. (2011). Radical vaginal trachelectomy (RVT) combined with laparoscopic lymphadenectomy: prospective study of 225 patients with early-stage cervical cancer. Int J Gynecol Cancer, 21(8), 1458-1464. doi:10.1097/IGC.0b013e3182216aa7

Larsson, G. L., Helenius, G., Andersson, S., Sorbe, B., & Karlsson, M. G. (2013). Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma. Gynecol Oncol, 129(2), 406-411. doi:10.1016/j.ygyno.2013.02.004

Leath, C. A., 3rd, Straughn, J. M., Jr., Estes, J. M., Kirby, T. O., Bhoola, S. M., Barnes, M. N., 3rd, Alvarez, R. D. (2004). The impact of aborted radical hysterectomy in patients with cervical carcinoma. Gynecol Oncol, 95(1), 204-207. doi:10.1016/j.ygyno.2004.07.034

Lecuru, F., Mathevet, P., Querleu, D., Leblanc, E., Morice, P., Darai, E., Dargent, D. (2011). Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol, 29(13), 1686-1691. doi:10.1200/JCO.2010.32.0432

Lee, C. L., Huang, K. G., Wang, C. J., Yen, C. F., & Soong, Y. K. (2000). Radical laparoscopic surgery for carcinoma of the cervical stump. J Am Assoc Gynecol Laparosc, 7(2), 241-244.

Lee, I. O., Lee, J. Y., Kim, S., Kim, S. W., Kim, Y. T., & Nam, E. J. (2017). Sentinel lymph node mapping with indocyanine green in vaginal cancer. J Gynecol Oncol, 28(4), e29. doi:10.3802/jgo.2017.28.e29

Lee, J., Lin, J. B., Chang, C. L., Jan, Y. T., Sun, F. J., Wu, M. H., & Chen, Y. J. (2017). Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience. Gynecol Oncol, 146(1), 20-26. doi:10.1016/j.ygyno.2017.04.016

Lee, J. Y., Kim, Y. H., Kim, M. J., Kim, K., Chung, H. H., Park, N. H., Kang, S. B. (2011). Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy. Arch Gynecol Obstet, 284(2), 477-482. doi:10.1007/s00404-010-1685-9

Lee, L. J., Das, I. J., Higgins, S. A., Jhingran, A., Small, W., Jr., Thomadsen, B., American Brachytherapy, S. (2012). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy, 11(1), 53-57. doi:10.1016/j.brachy.2011.07.001

Lee, S. H., Bae, J. W., Han, M., Cho, Y. J., Park, J. W., Oh, S. R., Lee, Y. (2020). Efficacy of nerve-sparing radical hysterectomy vs. conventional radical hysterectomy in early-stage cervical cancer: A systematic review and meta-analysis. Mol Clin Oncol, 12(2), 160-168. doi:10.3892/mco.2019.1959

Lee, W. R., Marcus, R. B., Jr., Sombeck, M. D., Mendenhall, W. M., Morgan, L. S., Freeman, D. E., & Million, R. R. (1994). Radiotherapy alone for carcinoma of the vagina: the importance of overall treatment time. Int J Radiat Oncol Biol Phys, 29(5), 983-988.

Lee, Y. J., Cho, A., Cho, B. C., Yun, M., Kim, S. K., Chang, J., Kim, J. H. (2009). High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer. Clin Cancer Res, 15(7), 2426-2432. doi:10.1158/1078-0432.CCR-08-2258

Lee, Y. S., Lee, T. H., Koo, T. B., Cho, Y. L., & Park, I. (2003). Laparoscopic radical parametrectomy including paraaortic and pelvic lymphadenectomy in women after prior hysterectomy: three cases. J Laparoendosc Adv Surg Tech A, 13(2), 123-126. doi:10.1089/109264203764654786

Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsague, X., Group, H. P. S. (2012). Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol, 13(1), 89-99. doi:10.1016/S1470-2045(11)70286-8

Lei, J., Andrae, B., Ploner, A., Lagheden, C., Eklund, C., Nordqvist Kleppe, S., Sparen, P. (2019). Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study. BMJ, 365, l1207. doi:10.1136/bmj.l1207

Lennox, G. K., & Covens, A. (2017). Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer? Gynecol Oncol, 144(1), 16-20. doi:10.1016/j.ygyno.2016.08.337

Leonhardt, H., Mellander, S., Snygg, J., & Lonn, L. (2008). Endovascular management of acute bleeding arterioenteric fistulas. Cardiovasc Intervent Radiol, 31(3), 542-549. doi:10.1007/s00270-007-9267-3

Leval, A., Herweijer, E., Ploner, A., Eloranta, S., Fridman Simard, J., Dillner, J., Arnheim-Dahlstrom, L. (2013). Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst, 105(7), 469-474. doi:10.1093/jnci/djt032

Levine, J. M., Kelvin, J. F., Quinn, G. P., & Gracia, C. R. (2015). Infertility in reproductive-age female cancer survivors. Cancer, 121(10), 1532-1539. doi:10.1002/cncr.29181

Li, Z., Barron, S., Hong, W., Karunamurthy, A., & Zhao, C. (2013). Surveillance for recurrent cancers and vaginal epithelial lesions in patients with invasive cervical cancer after hysterectomy: are vaginal cytology and high-risk human papillomavirus testing useful? Am J Clin Pathol, 140(5), 708-714. doi:10.1309/AJCPH4AFSZHU8EKK

Liang, J. A., Chen, S. W., Hung, Y. C., Yeh, L. S., Chang, W. C., Lin, W. C., & Chang, Y. Y. (2014). Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes. Int J Gynecol Cancer, 24(5), 901-907. doi:10.1097/IGC.0b013e31829f4dc5

Liang, Z., Xu, H., Chen, Y., Li, Y., Chang, Q., & Shi, C. (2006). Laparoscopic radical trachelectomy or parametrectomy and pelvic and para-aortic lymphadenectomy for cervical or vaginal stump carcinoma: report of six cases. Int J Gynecol Cancer, 16(4), 1713-1716. doi:10.1111/j.1525-1438.2006.00650.x

Lien, H. H., Blomlie, V., Iversen, T., Trope, C., Sundfor, K., & Abeler, V. M. (1993). Clinical stage I carcinoma of the cervix. Value of MR imaging in determining invasion into the parametrium. Acta Radiol, 34(2), 130-132.

Lim, C. S., Alexander-Sefre, F., Allam, M., Singh, N., Aleong, J. C., Al-Rawi, H., & Jacobs, I. J. (2008). Clinical value of immunohistochemically detected lymphovascular space invasion in early stage cervical carcinoma. Ann Surg Oncol, 15(9), 2581-2588. doi:10.1245/s10434-008-0014-z

Lim, K., Small, W., Jr., Portelance, L., Creutzberg, C., Jurgenliemk-Schulz, I. M., Mundt, A., Gyn, I. C. (2011). Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys, 79(2), 348-355. doi:10.1016/j.ijrobp.2009.10.075

Lim, K., Stewart, J., Kelly, V., Xie, J., Brock, K. K., Moseley, J., Milosevic, M. (2014). Dosimetrically triggered adaptive intensity modulated radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys, 90(1), 147-154. doi:10.1016/j.ijrobp.2014.05.039

Lin, A. J., Hassanzadeh, C., Markovina, S., Schwarz, J., & Grigsby, P. (2019). Brachytherapy and survival in small cell cancer of the cervix and uterus. Brachytherapy, 18(2), 163-170. doi:10.1016/j.brachy.2018.11.006

Lindegaard, J. C., Fokdal, L. U., Nielsen, S. K., Juul-Christensen, J., & Tanderup, K. (2013). MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol, 52(7), 1510-1519. doi:10.3109/0284186X.2013.818253

Lithner, M. Z., T. (1998). Does preoperative information increase the wellbeing of the patient after surgery? (in Swedish). Vård i Norden (Vol. 18).

Long, H. J., 3rd, Bundy, B. N., Grendys, E. C., Jr., Benda, J. A., McMeekin, D. S., Sorosky, J., Gynecologic Oncology Group, S. (2005). Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol, 23(21), 4626-4633. doi:10.1200/JCO.2005.10.021

Lopez-Acevedo, M., Lowery, W. J., Lowery, A. W., Lee, P. S., & Havrilesky, L. J. (2013). Palliative and hospice care in gynecologic cancer: a review. Gynecol Oncol, 131(1), 215-221. doi:10.1016/j.ygyno.2013.06.012

Lv, L., Sun, Y., Liu, H., Lou, J., & Peng, Z. (2010). Neoadjuvant chemotherapy followed by radical surgery and reconstruction of the vagina in a patient with stage II primary vaginal squamous carcinoma. J Obstet Gynaecol Res, 36(6), 1245-1248. doi:10.1111/j.1447-0756.2010.01245.x

Lv, Y., Wang, F., Yang, L., & Sun, G. (2014). Intensity-modulated whole pelvic radiotherapy provides effective dosimetric outcomes for cervical cancer treatment with lower toxicities. Cancer Radiother, 18(8), 745-752. doi:10.1016/j.canrad.2014.08.005

Macdonald, O. K., Chen, J., Dodson, M., Lee, C. M., & Gaffney, D. K. (2009). Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Am J Clin Oncol, 32(4), 411-416. doi:10.1097/COC.0b013e31819142dc

MacLennan, A. H. (2011). HRT in difficult circumstances: are there any absolute contraindications? Climacteric, 14(4), 409-417. doi:10.3109/13697137.2010.543496

Maduro, J. H., Pras, E., Willemse, P. H., & de Vries, E. G. (2003). Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev, 29(6), 471-488.

Maggen, C., van Gerwen, M., Van Calsteren, K., Vandenbroucke, T., & Amant, F. (2019). Management of cancer during pregnancy and current evidence of obstetric, neonatal and pediatric outcome: a review article. Int J Gynecol Cancer. doi:10.1136/ijgc-2018-000061

Maggioni, A., Minig, L., Zanagnolo, V., Peiretti, M., Sanguineti, F., Bocciolone, L., Velez, J. I. (2009). Robotic approach for cervical cancer: comparison with laparotomy: a case control study. Gynecol Oncol, 115(1), 60-64. doi:10.1016/j.ygyno.2009.06.039

Maggioni, A., Roviglione, G., Landoni, F., Zanagnolo, V., Peiretti, M., Colombo, N., Morrow, C. P. (2009). Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol, 114(1), 64-68. doi:10.1016/j.ygyno.2009.03.029

Magrina, J. F., Stanhope, C. R., & Weaver, A. L. (1997). Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol, 64(1), 130-135. doi:10.1006/gyno.1996.4532

Manuel, M. M., Cho, L. P., Catalano, P. J., Damato, A. L., Miyamoto, D. T., Tempany, C. M., Viswanathan, A. N. (2016). Outcomes with image-based interstitial brachytherapy for vaginal cancer. Radiother Oncol, 120(3), 486-492. doi:10.1016/j.radonc.2016.05.019

Marnitz, S., Kohler, C., Affonso, R. J., Schneider, A., Chiantera, V., Tsounoda, A., & Vercellino, F. (2012). Validity of laparoscopic staging to avoid adjuvant chemoradiation following radical surgery in patients with early cervical cancer. Oncology, 83(6), 346-353. doi:10.1159/000341659

Marnitz, S., Kohler, C., Muller, M., Behrens, K., Hasenbein, K., & Schneider, A. (2006). Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol, 103(3), 1023-1030. doi:10.1016/j.ygyno.2006.06.027

Marnitz, S., Kohler, C., Roth, C., Fuller, J., Hinkelbein, W., & Schneider, A. (2005). Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol, 99(3), 536-544. doi:10.1016/j.ygyno.2005.07.005

Marnitz, S., Martus, P., Kohler, C., Stromberger, C., Asse, E., Mallmann, P., Budach, V. (2016). Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group. Int J Radiat Oncol Biol Phys, 94(2), 243-253. doi:10.1016/j.ijrobp.2015.10.027

Matsuo, K., Machida, H., Shoupe, D., Melamed, A., Muderspach, L. I., Roman, L. D., & Wright, J. D. (2017). Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer. Obstet Gynecol, 129(1), 139-151. doi:10.1097/aog.0000000000001754

Mayadev, J., Lim, J., Durbin-Johnson, B., Valicenti, R., & Alvarez, E. (2018). Smoking Decreases Survival in Locally Advanced Cervical Cancer Treated With Radiation. Am J Clin Oncol, 41(3), 295-301. doi:10.1097/coc.0000000000000268

Mayr, N. A., Taoka, T., Yuh, W. T., Denning, L. M., Zhen, W. K., Paulino, A. C., Buatti, J. M. (2002). Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys, 52(1), 14-22.

McCann, G. A., Taege, S. K., Boutsicaris, C. E., Phillips, G. S., Eisenhauer, E. L., Fowler, J. M., Salani, R. (2013). The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol, 128(1), 44-48. doi:10.1016/j.ygyno.2012.10.028

McCormack, M., Kadalayil, L., Hackshaw, A., Hall-Craggs, M. A., Symonds, R. P., Warwick, V., Ledermann, J. A. (2013). A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. Br J Cancer, 108(12), 2464-2469. doi:10.1038/bjc.2013.230

McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008). Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol, 9(5), 425-434. doi:10.1016/S1470-2045(08)70103-7

McCusker, M. E., Cote, T. R., Clegg, L. X., & Tavassoli, F. J. (2003). Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. Gynecol Oncol, 88(3), 333-339.

McIndoe, W. A., McLean, M. R., Jones, R. W., & Mullins, P. R. (1984). The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol, 64(4), 451-458.

Meads, C., Auguste, P., Davenport, C., Malysiak, S., Sundar, S., Kowalska, M., Khan, K. (2013). Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling. Health Technol Assess, 17(12), 1-323. doi:10.3310/hta17120

Melamed, A., Margul, D. J., Chen, L., Keating, N. L., Del Carmen, M. G., Yang, J., Rauh-Hain, J. A. (2018). Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. N Engl J Med, 379(20), 1905-1914. doi:10.1056/NEJMoa1804923

Mendez, L. E., Penalver, M., McCreath, W., Bejarano, P., & Angioli, R. (2002). Radical vaginal trachelectomy after supracervical hysterectomy. Gynecol Oncol, 85(3), 545-547.

Milam, M. R., Frumovitz, M., dos Reis, R., Broaddus, R. R., Bassett, R. L., Jr., & Ramirez, P. T. (2007). Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer. Gynecol Oncol, 106(1), 12-15. doi:10.1016/j.ygyno.2007.04.010

Minig, L., Colombo, N., Zanagnolo, V., Landoni, F., Bocciolone, L., Cardenas-Rebollo, J. M., Maggioni, A. (2013). Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB. Int J Gynecol Cancer, 23(9), 1647-1654. doi:10.1097/IGC.0b013e3182a616d2

Mitchell, D. G., Snyder, B., Coakley, F., Reinhold, C., Thomas, G., Amendola, M. A., Hricak, H. (2009). Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study. Gynecol Oncol, 112(1), 95-103. doi:10.1016/j.ygyno.2008.10.005

Miyamoto, D. T., & Viswanathan, A. N. (2013). Concurrent chemoradiation for vaginal cancer. PLoS One, 8(6), e65048. doi:10.1371/journal.pone.0065048

Modarress, M., Maghami, F. Q., Golnavaz, M., Behtash, N., Mousavi, A., & Khalili, G. R. (2005). Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB-IIB bulky cervical cancer and with tumor diameter greater than 4 cm. Int J Gynecol Cancer, 15(3), 483-488. doi:10.1111/j.1525-1438.2005.15312.x

Mohamed, S., Kallehauge, J., Fokdal, L., Lindegaard, J. C., & Tanderup, K. (2015). Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy. Brachytherapy, 14(1), 23-28. doi:10.1016/j.brachy.2014.09.010

Moller, M. C., Radestad, A. F., von Schoultz, B., & Bartfai, A. (2013). Effect of estrogen and testosterone replacement therapy on cognitive fatigue. Gynecol Endocrinol, 29(2), 173-176. doi:10.3109/09513590.2012.730568

Monk, B. J., Sill, M. W., McMeekin, D. S., Cohn, D. E., Ramondetta, L. M., Boardman, C. H., Cella, D. (2009). Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol, 27(28), 4649-4655. doi:10.1200/JCO.2009.21.8909

Montz, F. J., Holschneider, C. H., Solh, S., Schuricht, L. C., & Monk, B. J. (1994). Small bowel obstruction following radical hysterectomy: risk factors, incidence, and operative findings. Gynecol Oncol, 53(1), 114-120. doi:10.1006/gyno.1994.1097

Moore, D. H., Blessing, J. A., McQuellon, R. P., Thaler, H. T., Cella, D., Benda, J., Rocereto, T. F. (2004). Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol, 22(15), 3113-3119. doi:10.1200/JCO.2004.04.170

Moore, D. H., Tian, C., Monk, B. J., Long, H. J., Omura, G. A., & Bloss, J. D. (2010). Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol, 116(1), 44-49. doi:10.1016/j.ygyno.2009.09.006

Morgan, S., Slodkowska, E., Parra-Herran, C., & Mirkovic, J. (2019). PD-L1, RB1 and mismatch repair protein immunohistochemical expression in neuroendocrine carcinoma, small cell type, of the uterine cervix. Histopathology, 74(7), 997-1004. doi:10.1111/his.13825

Morice, P., Castaigne, D., Pautier, P., Rey, A., Haie-Meder, C., Leblanc, M., & Duvillard, P. (1999). Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol, 73(1), 106-110. doi:10.1006/gyno.1998.5308

Morice, P., Deyrolle, C., Rey, A., Atallah, D., Pautier, P., Camatte, S., Castaigne, D. (2004). Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy. Ann Oncol, 15(2), 218-223.

Morice, P., Narducci, F., Mathevet, P., Marret, H., Darai, E., Querleu, D., College National des Gynecologues Obstetriciens, F. (2009). French recommendations on the management of invasive cervical cancer during pregnancy. Int J Gynecol Cancer, 19(9), 1638-1641. doi:10.1111/IGC.0b013e3181a83017

Morris, M., Gershenson, D. M., Eifel, P., Silva, E. G., Mitchell, M. F., Burke, T. W., & Wharton, J. T. (1992). Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol, 47(1), 62-65.

Motton, S., Houvenaeghel, G., Delannes, M., Querleu, D., Soule-Tholy, M., Hoff, J., & Leguevaque, P. (2010). Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy. Int J Gynecol Cancer, 20(2), 268-275.

Munstedt, K., von Georgi, R., Zygmunt, M., Misselwitz, B., Stillger, R., & Kunzel, W. (2002). Shortcomings and deficits in surgical treatment of gynecological cancers: a German problem only? Gynecol Oncol, 86(3), 337-343.

Nag, S., Cardenes, H., Chang, S., Das, I. J., Erickson, B., Ibbott, G. S., Image-Guided Brachytherapy Working, G. (2004). Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys, 60(4), 1160-1172. doi:10.1016/j.ijrobp.2004.04.032

Naik, R., Jackson, K. S., Lopes, A., Cross, P., & Henry, J. A. (2010). Laparoscopic assisted radical vaginal hysterectomy versus radical abdominal hysterectomy--a randomised phase II trial: perioperative outcomes and surgicopathological measurements. BJOG, 117(6), 746-751. doi:10.1111/j.1471-0528.2010.02479.x

Nam, H., Park, W., Huh, S. J., Bae, D. S., Kim, B. G., Lee, J. H., Ahn, Y. C. (2007). The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol Oncol, 107(2), 320-325. doi:10.1016/j.ygyno.2007.06.022

Narayan, K., Fisher, R. J., & Bernshaw, D. (2008). Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent. Int J Gynecol Cancer, 18(3), 525-533. doi:10.1111/j.1525-1438.2007.01050.x

Nasiell, K., Nasiell, M., & Vaclavinkova, V. (1983). Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol, 61(5), 609-614.

Naucler, P., Ryd, W., Tornberg, S., Strand, A., Wadell, G., Elfgren, K., Dillner, J. (2009). Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst, 101(2), 88-99. doi:10.1093/jnci/djn444

Nesvacil, N., Potter, R., Sturdza, A., Hegazy, N., Federico, M., & Kirisits, C. (2013). Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction. Radiother Oncol, 107(1), 75-81. doi:10.1016/j.radonc.2012.09.005

Nevelsky, A., Bar-Deroma, R., Cokal, G. Y., Rosenblatt, E., & Kuten, A. (2004). Definition of vaginal doses in intrauterine high-dose-rate brachytherapy. Brachytherapy, 3(2), 101-105. doi:10.1016/j.brachy.2004.05.002

Newman, W., & Cromer, J. K. (1959). The multicentric origin of carcinomas of the female anogenital tract. Surg Gynecol Obstet, 108(3), 273-281.

Nick, A. M., Lange, J., Frumovitz, M., Soliman, P. T., Schmeler, K. M., Schlumbrecht, M. P., Ramirez, P. T. (2011). Rate of vaginal cuff separation following laparoscopic or robotic hysterectomy. Gynecol Oncol, 120(1), 47-51. doi:10.1016/j.ygyno.2010.08.035

Norstrom, A., Jansson, I., & Andersson, H. (1997). Carcinoma of the uterine cervix in pregnancy. A study of the incidence and treatment in the western region of Sweden 1973 to 1992. Acta Obstet Gynecol Scand, 76(6), 583-589. doi:10.3109/00016349709024589

O'Brien, M. E., Ciuleanu, T. E., Tsekov, H., Shparyk, Y., Cucevia, B., Juhasz, G., Crofts, T. (2006). Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol, 24(34), 5441-5447. doi:10.1200/JCO.2006.06.5821

Oguntayo, O., Zayyan, M., Kolawole, A., Adewuyi, S., Ismail, H., & Koledade, K. (2011). Cancer of the cervix in Zaria, Northern Nigeria. Ecancermedicalscience, 5, 219. doi:10.3332/ecancer.2011.219

Oh, J., Seol, K. H., Lee, H. J., Choi, Y. S., Park, J. Y., & Bae, J. Y. (2017). Prophylactic extended-field irradiation with concurrent chemotherapy for pelvic lymph node-positive cervical cancer. Radiat Oncol J, 35(4), 349-358. doi:10.3857/roj.2017.00367

Oh, S., Stewart, J., Moseley, J., Kelly, V., Lim, K., Xie, J., Cho, Y. B. (2014). Hybrid adaptive radiotherapy with on-line MRI in cervix cancer IMRT. Radiother Oncol, 110(2), 323-328. doi:10.1016/j.radonc.2013.11.006

Olaitan, A., Murdoch, J., Anderson, R., James, J., Graham, J., & Barley, V. (2001). A critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study. Int J Gynecol Cancer, 11(5), 349-353.

Omar, T., & Marie, P. (2015). Should ovaries be removed or not in (early-stage) adenocarcinoma of the uterine cervix: a review. Gynecol Oncol, 136(2), 384-388. doi:10.1016/j.ygyno.2014.12.011

Oscarsson, N., Muller, B., Rosen, A., Lodding, P., Molne, J., Giglio, D., Seeman-Lodding, H. (2019). Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial. Lancet Oncol, 20(11), 1602-1614. doi:10.1016/s1470-2045(19)30494-2

Ostor, A. G. (1993). Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol, 12(2), 186-192.

Paavonen, J., Naud, P., Salmeron, J., Wheeler, C. M., Chow, S. N., Apter, D., Group, H. P. S. (2009). Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet, 374(9686), 301-314. doi:10.1016/S0140-6736(09)61248-4

Pahisa, J., Martinez-Roman, S., Martinez-Zamora, M. A., Torne, A., Caparros, X., Sanjuan, A., & Lejarcegui, J. A. (2008). Laparoscopic ovarian transposition in patients with early cervical cancer. Int J Gynecol Cancer, 18(3), 584-589. doi:10.1111/j.1525-1438.2007.01054.x

Palefsky, J. (2009). Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS, 4(1), 52-56. doi:10.1097/COH.0b013e32831a7246

Palsdottir, K., Fischerova, D., Franchi, D., Testa, A., Di Legge, A., & Epstein, E. (2015). Preoperative prediction of lymph node metastasis and deep stromal invasion in women with invasive cervical cancer: prospective multicenter study using 2D and 3D ultrasound. Ultrasound Obstet Gynecol, 45(4), 470-475. doi:10.1002/uog.14643

Pamnani, S. J., Sudenga, S. L., Rollison, D. E., Ingles, D. J., Abrahamsen, M., Villa, L. L., Giuliano, A. R. (2018). Recurrence of Genital Infections With 9 Human Papillomavirus (HPV) Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) Among Men in the HPV Infection in Men (HIM) Study. J Infect Dis, 218(8), 1219-1227. doi:10.1093/infdis/jiy300

Pantarotto, J., Malone, S., Dahrouge, S., Gallant, V., & Eapen, L. (2007). Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy. BJU Int, 99(3), 564-569. doi:10.1111/j.1464-410X.2006.06656.x

Paraghamian, S. E., Longoria, T. C., & Eskander, R. N. (2017). Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report. Gynecol Oncol Res Pract, 4, 3. doi:10.1186/s40661-017-0038-9

Park, J. Y., Joo, W. D., Chang, S. J., Kim, D. Y., Kim, J. H., Kim, Y. M., Nam, J. H. (2014). Long-term outcomes after fertility-sparing laparoscopic radical trachelectomy in young women with early-stage cervical cancer: an Asan Gynecologic Cancer Group (AGCG) study. J Surg Oncol, 110(3), 252-257. doi:10.1002/jso.23631

Park, J. Y., Kim, D. Y., Kim, J. H., Kim, Y. M., Kim, Y. T., & Nam, J. H. (2010). Management of occult invasive cervical cancer found after simple hysterectomy. Ann Oncol, 21(5), 994-1000. doi:10.1093/annonc/mdp426

Parker, W. H., Broder, M. S., Chang, E., Feskanich, D., Farquhar, C., Liu, Z., Manson, J. E. (2009). Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol, 113(5), 1027-1037. doi:10.1097/AOG.0b013e3181a11c64

Peccatori, F. A., Azim, H. A., Jr., Orecchia, R., Hoekstra, H. J., Pavlidis, N., Kesic, V., Group, E. G. W. (2013). Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 24 Suppl 6, vi160-170. doi:10.1093/annonc/mdt199

Pecorelli, S., Zigliani, L., & Odicino, F. (2009). Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet, 105(2), 107-108. doi:10.1016/j.ijgo.2009.02.009

Perez, C. A., Grigsby, P. W., Castro-Vita, H., & Lockett, M. A. (1995). Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys, 32(5), 1275-1288. doi:10.1016/0360-3016(95)00220-S

Perez, C. A., Grigsby, P. W., Garipagaoglu, M., Mutch, D. G., & Lockett, M. A. (1999). Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys, 44(1), 37-45.

Persson, J., Geppert, B., Lonnerfors, C., Bollino, M., & Masback, A. (2017). Description of a reproducible anatomically based surgical algorithm for detection of pelvic sentinel lymph nodes in endometrial cancer. Gynecol Oncol, 147(1), 120-125. doi:10.1016/j.ygyno.2017.07.131

Persson, J., Reynisson, P., Borgfeldt, C., Kannisto, P., Lindahl, B., & Bossmar, T. (2009). Robot assisted laparoscopic radical hysterectomy and pelvic lymphadenectomy with short and long term morbidity data. Gynecol Oncol, 113(2), 185-190. doi:10.1016/j.ygyno.2009.01.022

Persson, J., Salehi, S., Bollino, M., Lonnerfors, C., Falconer, H., & Geppert, B. (2019). Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. Eur J Cancer, 116, 77-85. doi:10.1016/j.ejca.2019.04.025

Petereit, D. G., Frank, S. J., Viswanathan, A. N., Erickson, B., Eifel, P., Nguyen, P. L., & Wazer, D. E. (2015). Brachytherapy: where has it gone? J Clin Oncol, 33(9), 980-982. doi:10.1200/JCO.2014.59.8128

Peters, W. A., 3rd, Liu, P. Y., Barrett, R. J., 2nd, Stock, R. J., Monk, B. J., Berek, J. S., Alberts, D. S. (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol, 18(8), 1606-1613.

Pettersson, B. F., Andersson, S., Hellman, K., & Hellstrom, A. C. (2010). Invasive carcinoma of the uterine cervix associated with pregnancy: 90 years of experience. Cancer, 116(10), 2343-2349. doi:10.1002/cncr.24971

Phippen, N. T., Leath, C. A., 3rd, Havrilesky, L. J., & Barnett, J. C. (2015). Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective? Gynecol Oncol, 136(1), 43-47. doi:10.1016/j.ygyno.2014.11.003

Pieterse, Q. D., Kenter, G. G., Gaarenstroom, K. N., Peters, A. A., Willems, S. M., Fleuren, G. J., & Trimbos, J. B. (2007). The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol, 33(2), 216-221. doi:10.1016/j.ejso.2006.09.037

Pieterse, Q. D., Kenter, G. G., Maas, C. P., de Kroon, C. D., Creutzberg, C. L., Trimbos, J. B., & Ter Kuile, M. M. (2013). Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer, 23(9), 1717-1725. doi:10.1097/IGC.0b013e3182a80a65

Pingley, S., Shrivastava, S. K., Sarin, R., Agarwal, J. P., Laskar, S., Deshpande, D. D., & Dinshaw, K. A. (2000). Primary carcinoma of the vagina: Tata Memorial Hospital experience. Int J Radiat Oncol Biol Phys, 46(1), 101-108.

Plante, M., Gregoire, J., Renaud, M. C., & Roy, M. (2011). The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol, 121(2), 290-297. doi:10.1016/j.ygyno.2010.12.345

Plante, M., Gregoire, J., Renaud, M. C., Sebastianelli, A., Grondin, K., Noel, P., & Roy, M. (2013). Simple vaginal trachelectomy in early-stage low-risk cervical cancer: a pilot study of 16 cases and review of the literature. Int J Gynecol Cancer, 23(5), 916-922. doi:10.1097/IGC.0b013e3182954ddf

Plante, M., Renaud, M. C., Sebastianelli, A., & Gregoire, J. (2017). Simple Vaginal Trachelectomy: A Valuable Fertility-Preserving Option in Early-Stage Cervical Cancer. Int J Gynecol Cancer, 27(5), 1021-1027. doi:10.1097/igc.0000000000000989

Polterauer, S., Grimm, C., Hofstetter, G., Concin, N., Natter, C., Sturdza, A., Heinze, G. (2012). Nomogram prediction for overall survival of patients diagnosed with cervical cancer. Br J Cancer, 107(6), 918-924. doi:10.1038/bjc.2012.340

Portenoy, R. K., & Itri, L. M. (1999). Cancer-related fatigue: guidelines for evaluation and management. Oncologist, 4(1), 1-10.

Potter, R., Dimopoulos, J., Georg, P., Lang, S., Waldhausl, C., Wachter-Gerstner, N., Kirisits, C. (2007). Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol, 83(2), 148-155. doi:10.1016/j.radonc.2007.04.012

Potter, R., Georg, P., Dimopoulos, J. C., Grimm, M., Berger, D., Nesvacil, N., Kirisits, C. (2011). Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol, 100(1), 116-123. doi:10.1016/j.radonc.2011.07.012

Potter, R., Haie-Meder, C., Van Limbergen, E., Barillot, I., De Brabandere, M., Dimopoulos, J., Group, G. E. W. (2006). Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol, 78(1), 67-77. doi:10.1016/j.radonc.2005.11.014

Pride, G. L., & Buchler, D. A. (1977). Carcinoma of vagina 10 or more years following pelvic irradiation therapy. Am J Obstet Gynecol, 127(5), 513-517.

Pukkala, E., & Weiderpass, E. (1999). Time trends in socio-economic differences in incidence rates of cancers of the breast and female genital organs (Finland, 1971-1995). Int J Cancer, 81(1), 56-61.

Querleu, D., & Morrow, C. P. (2008). Classification of radical hysterectomy. Lancet Oncol, 9(3), 297-303. doi:10.1016/s1470-2045(08)70074-3

Querleu, D., & Morrow, C. P. (2009). Classification of radical hysterectomy. Gynecol Oncol, 115(2), 314-315; author reply 315-316. doi:10.1016/j.ygyno.2009.07.027

Quinn, M. A., Benedet, J. L., Odicino, F., Maisonneuve, P., Beller, U., Creasman, W. T., Pecorelli, S. (2006). Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 95 Suppl 1, S43-103. doi:10.1016/S0020-7292(06)60030-1

Rajagopalan, M. S., Xu, K. M., Lin, J. F., Sukumvanich, P., Krivak, T. C., & Beriwal, S. (2014). Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: a National Cancer Data Base (NCDB) study. Gynecol Oncol, 135(3), 495-502. doi:10.1016/j.ygyno.2014.09.018

Rajaram, S., Maheshwari, A., & Srivastava, A. (2015). Staging for vaginal cancer. Best Pract Res Clin Obstet Gynaecol, 29(6), 822-832. doi:10.1016/j.bpobgyn.2015.01.006

Ramirez, P. T., Frumovitz, M., Pareja, R., Lopez, A., Vieira, M., Ribeiro, R., Obermair, A. (2018). Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med, 379(20), 1895-1904. doi:10.1056/NEJMoa1806395

Rasmusson, E.-M., & Thomé, B. (2008). Women’s Wishes and Need for Knowledge Concerning Sexuality and Relationships in Connection with Gynecological Cancer Disease. Sexuality and Disability, 26(4), 207. doi:10.1007/s11195-008-9097-5

Rasmusson, E. M., Plantin, L., & Elmerstig, E. (2013). 'Did they think I would understand all that on my own?' A questionnaire study about sexuality with Swedish cancer patients. Eur J Cancer Care (Engl), 22(3), 361-369. doi:10.1111/ecc.12039

Reingle Gonzalez, J. M., Jetelina, K. K., Olague, S., & Wondrack, J. G. (2018). Violence against women increases cancer diagnoses: Results from a meta-analytic review. Prev Med, 114, 168-179. doi:10.1016/j.ypmed.2018.07.008

Richard, S. D., Krivak, T. C., Castleberry, A., Beriwal, S., Kelley, J. L., 3rd, Edwards, R. P., & Sukumvanich, P. (2008). Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy. Gynecol Oncol, 109(1), 43-48. doi:10.1016/j.ygyno.2007.12.002

Rob, L., Skapa, P., & Robova, H. (2011). Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol, 12(2), 192-200. doi:10.1016/S1470-2045(10)70084-X

Robertson, N. L., Hricak, H., Sonoda, Y., Sosa, R. E., Benz, M., Lyons, G., Vargas, H. A. (2016). The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer. Gynecol Oncol, 140(3), 420-424. doi:10.1016/j.ygyno.2016.01.011

Rocca, W. A., Grossardt, B. R., de Andrade, M., Malkasian, G. D., & Melton, L. J., 3rd. (2006). Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol, 7(10), 821-828. doi:10.1016/S1470-2045(06)70869-5

Rogers, L., Siu, S. S., Luesley, D., Bryant, A., & Dickinson, H. O. (2012). Radiotherapy and chemoradiation after surgery for early cervical cancer. Cochrane Database Syst Rev, 5, CD007583. doi:10.1002/14651858.CD007583.pub3

Ronco, G., Dillner, J., Elfstrom, K. M., Tunesi, S., Snijders, P. J., Arbyn, M., International, H. P. V. s. w. g. (2014). Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet, 383(9916), 524-532. doi:10.1016/S0140-6736(13)62218-7

Rosa, D. D., Medeiros, L. R., Edelweiss, M. I., Pohlmann, P. R., & Stein, A. T. (2012). Adjuvant platinum-based chemotherapy for early stage cervical cancer. Cochrane Database Syst Rev, 6, CD005342. doi:10.1002/14651858.CD005342.pub3

Rotman, M., Sedlis, A., Piedmonte, M. R., Bundy, B., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (2006). A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys, 65(1), 169-176. doi:10.1016/j.ijrobp.2005.10.019

Rubens, D., Thornbury, J. R., Angel, C., Stoler, M. H., Weiss, S. L., Lerner, R. M., & Beecham, J. (1988). Stage IB cervical carcinoma: comparison of clinical, MR, and pathologic staging. AJR Am J Roentgenol, 150(1), 135-138. doi:10.2214/ajr.150.1.135

Rydzewska, L., Tierney, J., Vale, C. L., & Symonds, P. R. (2012). Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database Syst Rev, 12, CD007406. doi:10.1002/14651858.CD007406.pub3

Saatli, B., Olgan, S., Gorken, I. B., Uslu, T., Saygili, U., Dicle, N., Koyuncuoglu, M. (2014). Tumor-free distance from outermost layer of cervix is of prognostic value in surgically treated cervical cancer patients: a multicenter study. Arch Gynecol Obstet, 289(6), 1331-1335. doi:10.1007/s00404-014-3142-7

Sakuragi, N. (2007). Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol, 12(3), 165-175. doi:10.1007/s10147-007-0661-2

Sakuragi, N., Satoh, C., Takeda, N., Hareyama, H., Takeda, M., Yamamoto, R., Fujimoto, S. (1999). Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer, 85(7), 1547-1554.

Sala, E., Rockall, A., Rangarajan, D., & Kubik-Huch, R. A. (2010). The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Eur J Radiol, 76(3), 367-385. doi:10.1016/j.ejrad.2010.01.026

Sala, E., Rockall, A. G., Freeman, S. J., Mitchell, D. G., & Reinhold, C. (2013). The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology, 266(3), 717-740. doi:10.1148/radiol.12120315

Sala, E., Wakely, S., Senior, E., & Lomas, D. (2007). MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol, 188(6), 1577-1587. doi:10.2214/AJR.06.1196

Salani, R., Backes, F. J., Fung, M. F., Holschneider, C. H., Parker, L. P., Bristow, R. E., & Goff, B. A. (2011). Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol, 204(6), 466-478. doi:10.1016/j.ajog.2011.03.008

Salem, A., Salem, A. F., Al-Ibraheem, A., Lataifeh, I., Almousa, A., & Jaradat, I. (2011). Evidence for the use PET for radiation therapy planning in patients with cervical cancer: a systematic review. Hematol Oncol Stem Cell Ther, 4(4), 173-181. doi:10.5144/1658-3876.2011.173

Salvo, G., Gonzalez Martin, A., Gonzales, N. R., & Frumovitz, M. (2019). Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Int J Gynecol Cancer, 29(6), 986-995. doi:10.1136/ijgc-2019-000504

Salvo, G., Ramirez, P. T., Leitao, M., Cibula, D., Fotopoulou, C., Kucukmetin, A., Pareja, R. (2019). International radical trachelectomy assessment: IRTA study. Int J Gynecol Cancer, 29(3), 635-638. doi:10.1136/ijgc-2019-000273

Salvo, G., Ramirez, P. T., Levenback, C. F., Munsell, M. F., Euscher, E. D., Soliman, P. T., & Frumovitz, M. (2017). Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol, 145(1), 96-101. doi:10.1016/j.ygyno.2017.02.005

Samant, R., Lau, B., E, C., Le, T., & Tam, T. (2007). Primary vaginal cancer treated with concurrent chemoradiation using Cis-platinum. Int J Radiat Oncol Biol Phys, 69(3), 746-750. doi:10.1016/j.ijrobp.2007.04.015

Sapienza, L. G., Gomes, M. J. L., Calsavara, V. F., Leitao, M. M., Jr., & Baiocchi, G. (2017). Does para-aortic irradiation reduce the risk of distant metastasis in advanced cervical cancer? A systematic review and meta-analysis of randomized clinical trials. Gynecol Oncol, 144(2), 312-317. doi:10.1016/j.ygyno.2016.11.044

Sartori, E., Pasinetti, B., Carrara, L., Gambino, A., Odicino, F., & Pecorelli, S. (2007). Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Gynecol Oncol, 107(1 Suppl 1), S241-247. doi:10.1016/j.ygyno.2007.07.025

Satoh, T., Takei, Y., Treilleux, I., Devouassoux-Shisheboran, M., Ledermann, J., Viswanathan, A. N., Fujiwara, K. (2014). Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix. Int J Gynecol Cancer, 24(9 Suppl 3), S102-108. doi:10.1097/igc.0000000000000262

Saunamaki, N., & Engstrom, M. (2014). Registered nurses' reflections on discussing sexuality with patients: responsibilities, doubts and fears. J Clin Nurs, 23(3-4), 531-540. doi:10.1111/jocn.12155

Schiffman, M., Glass, A. G., Wentzensen, N., Rush, B. B., Castle, P. E., Scott, D. R., Burk, R. D. (2011). A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev, 20(7), 1398-1409. doi:10.1158/1055-9965.Epi-11-0206

Schiffman, M., & Kjaer, S. K. (2003). Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr(31), 14-19.

Schockaert, S., Poppe, W., Arbyn, M., Verguts, T., & Verguts, J. (2008). Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study. Am J Obstet Gynecol, 199(2), 113 e111-115. doi:10.1016/j.ajog.2008.02.026

Schwarz, J. K., Siegel, B. A., Dehdashti, F., & Grigsby, P. W. (2012). Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys, 83(1), 185-190. doi:10.1016/j.ijrobp.2011.05.053

Sedlis, A., Bundy, B. N., Rotman, M. Z., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (1999). A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol, 73(2), 177-183. doi:10.1006/gyno.1999.5387

Sekse, R. J., Hufthammer, K. O., & Vika, M. E. (2015). Fatigue and quality of life in women treated for various types of gynaecological cancers: a cross-sectional study. J Clin Nurs, 24(3-4), 546-555. doi:10.1111/jocn.12647

Selman, T. J., Mann, C., Zamora, J., Appleyard, T. L., & Khan, K. (2008). Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ, 178(7), 855-862. doi:10.1503/cmaj.071124

Serrano, B., de Sanjose, S., Tous, S., Quiros, B., Munoz, N., Bosch, X., & Alemany, L. (2015). Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer, 51(13), 1732-1741. doi:10.1016/j.ejca.2015.06.001

Sevin, B. U., Method, M. W., Nadji, M., Lu, Y., & Averette, H. A. (1996). Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer, 77(8), 1489-1493. doi:10.1002/(SICI)1097-0142(19960415)77:8<1489::AID-CNCR10>3.0.CO;2-W

Shafer, A., & Boggess, J. F. (2008). Robotic-assisted endometrial cancer staging and radical hysterectomy with the da Vinci surgical system. Gynecol Oncol, 111(2 Suppl), S18-23. doi:10.1016/j.ygyno.2008.07.023

Shah, A. N., & Olah, K. S. (2002). Cervical stump carcinoma following subtotal hysterectomy. J Obstet Gynaecol, 22(6), 701. doi:10.1080/014436102762062493

Shah, C. A., Goff, B. A., Lowe, K., Peters, W. A., 3rd, & Li, C. I. (2009). Factors affecting risk of mortality in women with vaginal cancer. Obstet Gynecol, 113(5), 1038-1045. doi:10.1097/AOG.0b013e31819fe844

Sharma, S., Odunsi, K., Driscoll, D., & Lele, S. (2005). Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute. Int J Gynecol Cancer, 15(3), 475-482. doi:10.1111/j.1525-1438.2005.15311.x

Sheets, E. E., Berman, M. L., Hrountas, C. K., Liao, S. Y., & DiSaia, P. J. (1988). Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol, 71(1), 10-14.

Shepherd, F. A., Evans, W. K., MacCormick, R., Feld, R., & Yau, J. C. (1987). Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer. Cancer Treat Rep, 71(10), 941-944.

Shield, P. W., Wright, R. G., Free, K., & Daunter, B. (1991). The accuracy of cervicovaginal cytology in the detection of recurrent cervical carcinoma following radiotherapy. Gynecol Oncol, 41(3), 223-229.

Shimada, M., Kigawa, J., Nishimura, R., Yamaguchi, S., Kuzuya, K., Nakanishi, T., Terakawa, N. (2006). Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol, 101(2), 234-237. doi:10.1016/j.ygyno.2005.10.004

Shingleton, H. M., Bell, M. C., Fremgen, A., Chmiel, J. S., Russell, A. H., Jones, W. B., Clive, R. E. (1995). Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer, 76(10 Suppl), 1948-1955.

Sia, T. Y., Chen, L., Melamed, A., Tergas, A. I., Khoury-Collado, F., Hou, J. Y., Wright, J. D. (2019). Trends in Use and Effect on Survival of Simple Hysterectomy for Early-Stage Cervical Cancer. Obstet Gynecol, 134(6), 1132-1143. doi:10.1097/AOG.0000000000003523

Silins, I., Ryd, W., Strand, A., Wadell, G., Tornberg, S., Hansson, B. G., Rylander, E. (2005). Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer, 116(1), 110-115. doi:10.1002/ijc.20970

Simms, K. T., Steinberg, J., Caruana, M., Smith, M. A., Lew, J. B., Soerjomataram, I., Canfell, K. (2019). Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study. Lancet Oncol, 20(3), 394-407. doi:10.1016/s1470-2045(18)30836-2

Singh, N., & Arif, S. (2004). Histopathologic parameters of prognosis in cervical cancer--a review. Int J Gynecol Cancer, 14(5), 741-750. doi:10.1111/j.1048-891X.2004.014504.x

Singh, P., Tripcony, L., & Nicklin, J. (2012). Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix. Int J Gynecol Cancer, 22(1), 115-122. doi:10.1097/IGC.0b013e31822fa8bb

Sironi, S., Belloni, C., Taccagni, G. L., & DelMaschio, A. (1991). Carcinoma of the cervix: value of MR imaging in detecting parametrial involvement. AJR Am J Roentgenol, 156(4), 753-756. doi:10.2214/ajr.156.4.2003441

Skoogh, J., Steineck, G., Stierner, U., Cavallin-Stahl, E., Wilderang, U., Wallin, A., Johansson, B. (2012). Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment. Acta Oncol, 51(2), 185-197. doi:10.3109/0284186x.2011.602113

Slama, J., Dundr, P., Dusek, L., & Cibula, D. (2013). High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol, 129(2), 384-388. doi:10.1016/j.ygyno.2013.02.001

Small, W., Jr., Mell, L. K., Anderson, P., Creutzberg, C., De Los Santos, J., Gaffney, D., Mundt, A. J. (2008). Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys, 71(2), 428-434. doi:10.1016/j.ijrobp.2007.09.042

Smelov, V., Elfstrom, K. M., Johansson, A. L., Eklund, C., Naucler, P., Arnheim-Dahlstrom, L., & Dillner, J. (2015). Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial. Int J Cancer, 136(5), 1171-1180. doi:10.1002/ijc.29085

Smith, E. M., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Shapiro, C. L. (2013). Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA, 309(13), 1359-1367. doi:10.1001/jama.2013.2813

Smith, J. R., Boyle, D. C., Corless, D. J., Ungar, L., Lawson, A. D., Del Priore, G., Bridges, J. E. (1997). Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma. Br J Obstet Gynaecol, 104(10), 1196-1200.

Sobin, L. H., Gospodarowicz, M. K., & Wittekind, C. (2009). TNM classification of malignant tumours. New York: Wiley-Blackwell.

Sonoda, Y., Abu-Rustum, N. R., Gemignani, M. L., Chi, D. S., Brown, C. L., Poynor, E. A., & Barakat, R. R. (2004). A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible? Gynecol Oncol, 95(3), 534-538. doi:10.1016/j.ygyno.2004.07.060

Speiser, D., Kohler, C., Schneider, A., & Mangler, M. (2013). Radical vaginal trachelectomy: a fertility-preserving procedure in early cervical cancer in young women. Dtsch Arztebl Int, 110(17), 289-295. doi:10.3238/arztebl.2013.0289

Speiser, D., Mangler, M., Kohler, C., Hasenbein, K., Hertel, H., Chiantera, V., Lanowska, M. (2011). Fertility outcome after radical vaginal trachelectomy: a prospective study of 212 patients. Int J Gynecol Cancer, 21(9), 1635-1639. doi:10.1097/IGC.0b013e3182230294

Stanhope, C. R., Webb, M. J., & Podratz, K. C. (1990). Pelvic exenteration for recurrent cervical cancer. Clin Obstet Gynecol, 33(4), 897-909.

Stenstedt, K., Hellstrom, A. C., Fridsten, S., & Blomqvist, L. (2011). Impact of MRI in the management and staging of cancer of the uterine cervix. Acta Oncol, 50(3), 420-426. doi:10.3109/0284186X.2010.541932

Stern, P. L., van der Burg, S. H., Hampson, I. N., Broker, T. R., Fiander, A., Lacey, C. J., Einstein, M. H. (2012). Therapy of human papillomavirus-related disease. Vaccine, 30 Suppl 5, F71-82. doi:10.1016/j.vaccine.2012.05.091

Stewart, J., Lim, K., Kelly, V., Xie, J., Brock, K. K., Moseley, J., Milosevic, M. (2010). Automated weekly replanning for intensity-modulated radiotherapy of cervix cancer. Int J Radiat Oncol Biol Phys, 78(2), 350-358. doi:10.1016/j.ijrobp.2009.07.1699

Stinesen Kollberg, K., Waldenstrom, A. C., Bergmark, K., Dunberger, G., Rossander, A., Wilderang, U., Steineck, G. (2015). Reduced vaginal elasticity, reduced lubrication, and deep and superficial dyspareunia in irradiated gynecological cancer survivors. Acta Oncol, 54(5), 772-779. doi:10.3109/0284186x.2014.1001036

Stock, R. G., Chen, A. S., & Seski, J. (1995). A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. Gynecol Oncol, 56(1), 45-52. doi:10.1006/gyno.1995.1008

Strander, B., Hallgren, J., & Sparen, P. (2014). Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality. BMJ, 348, f7361. doi:10.1136/bmj.f7361

Strauss, H. G., Haensgen, G., Dunst, J., Hayward, C. R., Burger, H. U., Scherhag, A., & Koelbl, H. (2008). Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer. Int J Gynecol Cancer, 18(3), 515-524. doi:10.1111/j.1525-1438.2007.01032.x

Strålsäkerhetsmyndigheten. SSMFS 2018:5 Strålsäkerhetsmyndighetens föreskrifter och allmänna råd om medicinska exponeringar. Retrieved from https://www.stralsakerhetsmyndigheten.se/publikationer/foreskrifter/ssmfs-2018/ssmfs-20185/

Subak, L. L., Hricak, H., Powell, C. B., Azizi, L., & Stern, J. L. (1995). Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol, 86(1), 43-50.

Syrjanen, K., Hakama, M., Saarikoski, S., Vayrynen, M., Yliskoski, M., Syrjanen, S., Castren, O. (1990). Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis, 17(1), 15-19.

Tanderup, K., Eifel, P. J., Yashar, C. M., Potter, R., & Grigsby, P. W. (2014). Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional. Int J Radiat Oncol Biol Phys, 88(3), 537-539. doi:10.1016/j.ijrobp.2013.11.011

Taylor, A., & Powell, M. E. (2008). An assessment of interfractional uterine and cervical motion: implications for radiotherapy target volume definition in gynaecological cancer. Radiother Oncol, 88(2), 250-257. doi:10.1016/j.radonc.2008.04.016

Taylor, A., Rockall, A. G., Reznek, R. H., & Powell, M. E. (2005). Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys, 63(5), 1604-1612. doi:10.1016/j.ijrobp.2005.05.062

Tempfer, C. B., Tischoff, I., Dogan, A., Hilal, Z., Schultheis, B., Kern, P., & Rezniczek, G. A. (2018). Neuroendocrine carcinoma of the cervix: a systematic review of the literature. BMC Cancer, 18(1), 530. doi:10.1186/s12885-018-4447-x

Testa, A. C., Di Legge, A., De Blasis, I., Moruzzi, M. C., Bonatti, M., Collarino, A., Manfredi, R. (2014). Imaging techniques for the evaluation of cervical cancer. Best Pract Res Clin Obstet Gynaecol, 28(5), 741-768. doi:10.1016/j.bpobgyn.2014.04.009

Testa, A. C., Di Legge, A., Virgilio, B., Bonatti, M., Manfredi, R., Mirk, P., & Rufini, V. (2014). Which imaging technique should we use in the follow up of gynaecological cancer? Best Pract Res Clin Obstet Gynaecol, 28(5), 769-791. doi:10.1016/j.bpobgyn.2014.04.008

Testa, A. C., Ludovisi, M., Manfredi, R., Zannoni, G., Gui, B., Basso, D., Ferrandina, G. (2009). Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. Ultrasound Obstet Gynecol, 34(3), 335-344. doi:10.1002/uog.7325

Tewari, K. S., Sill, M. W., Long, H. J., 3rd, Penson, R. T., Huang, H., Ramondetta, L. M., Monk, B. J. (2014). Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med, 370(8), 734-743. doi:10.1056/NEJMoa1309748

Thamronganantasakul, K., Supakalin, N., Kietpeerakool, C., Pattanittum, P., & Lumbiganon, P. (2018). Extended-field radiotherapy for locally advanced cervical cancer. Cochrane Database Syst Rev, 10, Cd012301. doi:10.1002/14651858.CD012301.pub2

Thigpen, J. T., Blessing, J. A., Homesley, H. D., Berek, J. S., & Creasman, W. T. (1986). Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group Study. Gynecol Oncol, 23(1), 101-104.

Thigpen, T., Shingleton, H., Homesley, H., Lagasse, L., & Blessing, J. (1981). Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer, 48(4), 899-903.

Thoeny, H. C., Forstner, R., & De Keyzer, F. (2012). Genitourinary applications of diffusion-weighted MR imaging in the pelvis. Radiology, 263(2), 326-342. doi:10.1148/radiol.12110446

Thomas, G., Ali, S., Hoebers, F. J., Darcy, K. M., Rodgers, W. H., Patel, M., Begg, A. C. (2008). Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer. Gynecol Oncol, 108(2), 317-325. doi:10.1016/j.ygyno.2007.10.011

Thomas, G. M. (1999). Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy. N Engl J Med, 340(15), 1198-1200. doi:10.1056/NEJM199904153401509

Thomeer, M. G., Gerestein, C., Spronk, S., van Doorn, H. C., van der Ham, E., & Hunink, M. G. (2013). Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis. Eur Radiol, 23(7), 2005-2018. doi:10.1007/s00330-013-2783-4

Thomeer, M. G., Vandecaveye, V., Braun, L., Mayer, F., Franckena-Schouten, M., de Boer, P.,  van Doorn, H. (2019). Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre study. Eur Radiol, 29(1), 309-318. doi:10.1007/s00330-018-5510-3

Tjalma, W. A., Monaghan, J. M., de Barros Lopes, A., Naik, R., Nordin, A. J., & Weyler, J. J. (2001). The role of surgery in invasive squamous carcinoma of the vagina. Gynecol Oncol, 81(3), 360-365. doi:10.1006/gyno.2001.6171

Togashi, K., Nishimura, K., Sagoh, T., Minami, S., Noma, S., Fujisawa, I., et al. (1989). Carcinoma of the cervix: staging with MR imaging. Radiology, 171(1), 245-251. doi:10.1148/radiology.171.1.2928532

Trimbos, J. B., Franchi, M., Zanaboni, F., Velden, J., & Vergote, I. (2004). 'State of the art' of radical hysterectomy; current practice in European oncology centres. Eur J Cancer, 40(3), 375-378.

Urbanski, K., Kojs, Z., Reinfuss, M., & Fabisiak, W. (1996). Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol, 60(1), 16-21. doi:10.1006/gyno.1996.0004

Vair, B., Altman, A. D., & Nelson, G. (2015). Time to surgery and the risk of cancer progression in patients with gynaecologic cancers of the lower genital tract. J Obstet Gynaecol Can, 37(4), 338-344.

Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Munoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189(1), 12-19. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

van der Stege, J. G., Groen, H., van Zadelhoff, S. J., Lambalk, C. B., Braat, D. D., van Kasteren, Y. M., Hoek, A. (2008). Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause, 15(1), 23-31.

van Kol, K. G. G., Vergeldt, T. F. M., & Bekkers, R. L. M. (2019). Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates. Gynecol Oncol, 155(3), 515-521. doi:10.1016/j.ygyno.2019.09.025

van Lonkhuijzen, L., & Thomas, G. (2011). Palliative radiotherapy for cervical carcinoma, a systematic review. Radiother Oncol, 98(3), 287-291. doi:10.1016/j.radonc.2011.01.009

van Oortmarssen, G. J., & Habbema, J. D. (1991). Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer, 64(3), 559-565.

Vandenbroucke, T., Verheecke, M., Fumagalli, M., Lok, C., & Amant, F. (2017). Effects of cancer treatment during pregnancy on fetal and child development. Lancet Child Adolesc Health, 1(4), 302-310. doi:10.1016/s2352-4642(17)30091-3

Warr, D. (2014). Prognostic factors for chemotherapy induced nausea and vomiting. Eur J Pharmacol, 722, 192-196. doi:10.1016/j.ejphar.2013.10.015

Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015). Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin, 65(2), 123-138. doi:10.3322/caac.21258

Vega, J. N., Dumas, J., & Newhouse, P. A. (2018). Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause. Psychooncology, 27(9), 2198-2205. doi:10.1002/pon.4796

Wharton, J. T., Tortolero-Luna, G., Linares, A. C., Malpica, A., Baker, V. V., Cook, E., Follen Mitchell, M. (1996). Vaginal intraepithelial neoplasia and vaginal cancer. Obstet Gynecol Clin North Am, 23(2), 325-345.

Wiggins, D. L., Wood, R., Granai, C. O., & Dizon, D. S. (2007). Sex, intimacy, and the gynecologic oncologists: survey results of the New England Association of Gynecologic Oncologists (NEAGO). J Psychosoc Oncol, 25(4), 61-70. doi:10.1300/J077v25n04_04

Winer, I., Alvarado-Cabrero, I., Hassan, O., Ahmed, Q. F., Alosh, B., Bandyopadhyay, S., Ali-Fehmi, R. (2015). The prognostic significance of histologic type in early stage cervical cancer - A multi-institutional study. Gynecol Oncol, 137(3), 474-478. doi:10.1016/j.ygyno.2015.02.005

Winer, R. L., Hughes, J. P., Feng, Q., O'Reilly, S., Kiviat, N. B., Holmes, K. K., & Koutsky, L. A. (2006). Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med, 354(25), 2645-2654. doi:10.1056/NEJMoa053284

Vistad, I., Kristensen, G. B., Fossa, S. D., Dahl, A. A., & Morkrid, L. (2009). Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys, 73(4), 1141-1147. doi:10.1016/j.ijrobp.2008.05.064

Viswanathan, A. N., Beriwal, S., De Los Santos, J. F., Demanes, D. J., Gaffney, D., Hansen, J., American Brachytherapy, S. (2012). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy, 11(1), 47-52. doi:10.1016/j.brachy.2011.07.002

Viswanathan, A. N., Deavers, M. T., Jhingran, A., Ramirez, P. T., Levenback, C., & Eifel, P. J. (2004). Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol, 93(1), 27-33. doi:10.1016/j.ygyno.2003.12.027

Viswanathan, A. N., Thomadsen, B., American Brachytherapy Society Cervical Cancer Recommendations, C., & American Brachytherapy, S. (2012). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy, 11(1), 33-46. doi:10.1016/j.brachy.2011.07.003

Vitali, M., Ripamonti, C. I., Roila, F., Proto, C., Signorelli, D., Imbimbo, M., Lo Russo, G. (2017). Cognitive impairment and chemotherapy: a brief overview. Crit Rev Oncol Hematol, 118, 7-14. doi:10.1016/j.critrevonc.2017.08.001

Withers, H. R., & Suwinski, R. (1998). Radiation dose response for subclinical metastases. Semin Radiat Oncol, 8(3), 224-228.

Woo, S., Suh, C. H., Kim, S. Y., Cho, J. Y., & Kim, S. H. (2018). Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: An updated systematic review and meta-analysis of the literature between 2012 and 2016. Eur Radiol, 28(2), 530-541. doi:10.1007/s00330-017-4958-x

Woodman, C. B., Collins, S., Winter, H., Bailey, A., Ellis, J., Prior, P., Young, L. S. (2001). Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet, 357(9271), 1831-1836. doi:10.1016/S0140-6736(00)04956-4

Woodman, C. B., Collins, S. I., & Young, L. S. (2007). The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer, 7(1), 11-22. doi:10.1038/nrc2050

World Health Organization, International Agency for Research on, C., & Kurman, R. J. (2014). WHO Classification of Tumours of Female Reproductive Organs [Elektronisk resurs]: International Agency for Research on Cancer.

Wright, J. D., Grigsby, P. W., Brooks, R., Powell, M. A., Gibb, R. K., Gao, F., Mutch, D. G. (2007). Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer, 110(6), 1281-1286. doi:10.1002/cncr.22899

Wright, T. C., Jr., Koulos, J., Schnoll, F., Swanbeck, J., Ellerbrock, T. V., Chiasson, M. A., & Richart, R. M. (1994). Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol, 55(2), 253-258. doi:10.1006/gyno.1994.1286

Wu, Y., Li, Z., Wu, H., & Yu, J. (2013). Sentinel lymph node biopsy in cervical cancer: A meta-analysis. Mol Clin Oncol, 1(6), 1025-1030. doi:10.3892/mco.2013.168

Xiao, Y., Wei, J., Zhang, Y., & Xiong, W. (2014). Positron emission tomography alone, positron emission tomography-computed tomography and computed tomography in diagnosing recurrent cervical carcinoma: a systematic review and meta-analysis. Arch Med Sci, 10(2), 222-231. doi:10.5114/aoms.2014.42572

Xing, D., Zheng, G., Schoolmeester, J. K., Li, Z., Pallavajjala, A., Haley, L., Ronnett, B. M. (2018). Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix. Am J Surg Pathol, 42(6), 750-760. doi:10.1097/pas.0000000000001042

Yalvac, S., Kayikcioglu, F., Boran, N., Tulunay, G., Kose, M. F., Bilgic, S., & Haberal, A. (2002). Embolization of uterine artery in terminal stage cervical cancers. Cancer Invest, 20(5-6), 754-758.

Yamaguchi, S., Fujiwara, K., Sato, S., Nagao, S., Takehara, K., Nishimura, M., Tanioka, M. (2014). Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advaned cervical cancer. Final results of a multicenter phase II study (Sankai gynecology study group 013), JCO 32:5supplement, Abstract 5526.

Yang, B., Zhu, L., Cheng, H., Li, Q., Zhang, Y., & Zhao, Y. (2012). Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis. Radiat Oncol, 7, 197. doi:10.1186/1748-717X-7-197

Yang, W. T., Walkden, S. B., Ho, S., Cheung, T. H., Lam, S. K., Teo, J., & Metreweli, C. (1996). Transrectal ultrasound in the evaluation of cervical carcinoma and comparison with spiral computed tomography and magnetic resonance imaging. Br J Radiol, 69(823), 610-616. doi:10.1259/0007-1285-69-823-610

Young, P., Daniel, B., Sommer, G., Kim, B., & Herfkens, R. (2012). Intravaginal gel for staging of female pelvic cancers--preliminary report of safety, distention, and gel-mucosal contrast during magnetic resonance examination. J Comput Assist Tomogr, 36(2), 253-256. doi:10.1097/RCT.0b013e3182483c05

Zand, B., Euscher, E. D., Soliman, P. T., Schmeler, K. M., Coleman, R. L., Frumovitz, M., Ramirez, P. T. (2010). Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol, 119(3), 422-425. doi:10.1016/j.ygyno.2010.08.012

Zhang, G., Fu, C., Zhang, Y., Wang, J., Qiao, N., Yang, Q., & Cheng, Y. (2012). Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution. Int J Gynecol Cancer, 22(7), 1220-1225. doi:10.1097/IGC.0b013e3182643b7c

Zivanovic, O., Leitao, M. M., Jr., Park, K. J., Zhao, H., Diaz, J. P., Konner, J., Aghajanian, C. (2009). Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. Gynecol Oncol, 112(3), 590-593. doi:10.1016/j.ygyno.2008.11.010

Zola, P., Fuso, L., Mazzola, S., Piovano, E., Perotto, S., Gadducci, A., Scambia, G. (2007). Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol Oncol, 107(1 Suppl 1), S150-154. doi:10.1016/j.ygyno.2007.07.028

Zolciak-Siwinska, A., & Jonska-Gmyrek, J. (2014). Glassy cell carcinoma of the cervix: a literature review. Eur J Obstet Gynecol Reprod Biol, 179, 232-235. doi:10.1016/j.ejogrb.2014.03.035

Nästa kapitel
21 Vårdprogramgruppen